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Bone disease and injury is expected to increase in the near future due to an ageing 
population, causing social and economic burden due to disability and lowered quality 
of life. Critical sized defects, the smallest bony injury that will not heal completely 
over the lifetime of an individual, are significant orthopedic and oral-maxillofacial 
issues, as they require bone grafts to facilitate repair. As the gold standard autograft is 
in short supply with additional disadvantages, bone tissue engineering seeks to 
alleviate this demand. It combines cells isolated from patients with biomaterials to 
produce bone tissue. This research looks into the feasibility of bone banking: the 
cryopreservation and storage of a patient’s cells that can be reanimated at the time of 
injury or disease and the engineering of a bone graft in vitro. 
 
Chitosan and nano-hydroxyapatite composite scaffolds were fabricated to produce 
appropriate pore diameters and porosities. A final concentration of 8% (w/v) chitosan 
and 5% (w/v) nano-hydroxyapatite were used in the final scaffold, where imaging 
studies (scanning electron microscopy, micro-computed tomography) showed pore 
diameters with a 106 µm average with 79% porosity. These scaffolds were subjected 
to testing, such as degradation, pH, sterilization, swelling studies, Fourier transform 
infrared spectroscopy, and energy dispersive X-ray spectroscopy in order to 
characterize physical and chemical properties.  
 
Using an osteogenic sarcoma cell line (SAOS-2), scaffolds were then subjected to in 
vitro cell studies including the LIVE/DEAD® viability assay and the MTS cell 
proliferation assay to characterize biocompatibility. Results indicate scaffolds are 
biocompatible and non-cytotoxic. Further three-dimensional in vitro testing was 
performed using SAOS-2 in a custom-made perfusion bioreactor for 14 days. After 
this period isolated cells were detected on the scaffold using histological and 
 iii 
fluorescent microscopy techniques. Further in vitro testing was investigated using 
mesenchymal stem cells isolated from rats. However, these cells reached senescence 
rapidly, therefore, the supply of cells were limited and differentiation down the 
osteoblastic lineage and three-dimensional culture was unable to be accomplished.  
 
This research demonstrated the development of a biocompatible scaffold with 
appropriate structural parameters that promote viable cells when cultured in a 
bioreactor. Future study should investigate the scaffolds mechanical and structural 
properties to determine suitability for bearing load and the production of a 
homogenous scaffold matrix that results in homogenous osteoid tissue. Cell culture 
optimization in terms of mesenchymal stem cell proliferation and extracellular matrix 
production also needs to be investigated in terms of modifying tissue culture factors 
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1 Introduction  
 
Due to demographic changes, clinicians are exposed to increasing numbers of 
geriatric diseases such as osteoarthritis and osteoporosis (1). According to Chang and 
Xiao, bone diseases affect 10 to 12 million people in the United States and there are 
an estimated 1.5 million fractures every year. In the United Kingdom, a fracture 
occurs every 30 seconds due to osteoporosis. In China, 3 million individuals suffer 
from bone defects or injury every year. More than 500,000 bone graft procedures are 
performed in the United States, with approximately 2.2 million performed worldwide, 
and estimated to cost $2.5 billion per year. These figures illustrate the impact bone 
disease and injury has on society. It is expected to get worse, as bone grafting 
procedures will increase while the challenge to repairing bone defects remains 
unsolved (2,3). Regenerative medicine can solve these detrimental problems in 
humans, though further research is required (2).  
 
Although the body has a high healing potential, bone loss remains an unsolved 
clinical problem. A critical size defect is bone loss of a certain size that does not heal 
and remains a huge problem with more than 40% of cases having inadequate autograft 
supplies. The ‘gold standard’ autograft has the best clinical outcome, but its 
shortcomings are limited availability and the need of a second surgical site (1). 
Although allografts, xenografts and synthetic bone substitutes are widely available 
there are many risks including rejection, disease transmission and suboptimal healing 
(4). There is increasing demand for superior bone substitutes because of the 
disadvantages with current ones. To improve the healing potential of these synthetic 
bone graft substitutes, scaffolds should be seeded with osteogenic cells obtained from 
the patient (1), which is a premise of engineered tissue. 
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Tissue loss is a common theme in surgery, and organs for transplantation are always 
in demand, with immunosuppressive agents causing additional problems. The goal of 
tissue engineering is to develop new biotechnologies in order to restore structure and 
function of damaged tissue (5). Bone is the second most transplanted tissue in the 
human body after blood (3) and has the highest potential for regeneration in the body 
(5). Simply put, tissue engineering is the use of cells and supporting structures and/or 
biomolecules to regenerate tissue (6). Scaffolds with three-dimensional, 
interconnected, porous architectures are commonly used to provide a template for 
tissues to regenerate. Osteoprogenitor cells can be taken by bone marrow biopsy 
sampling, expanded in vitro and seeded onto the scaffold. This cell-scaffold construct 
can be cultured in three-dimensions in a bioreactor until an appropriate graft is 
formed. This final 3D cell-scaffold construct can be implanted into the patient without 
rejection and is theoretically unlimited in supply (5). 
 
In the research undertaken for this thesis, the focus is placed on the development of an 
appropriate scaffold for cell viability and proliferation, so when cultured in a 
bioreactor, produces a 3D sample of osteoid. A major limitation of bone tissue 
engineering is the development of mechanically sound scaffolds that have porous 
interconnectivity, allowing appropriate nutrient and waste perfusion, and cell 
proliferation. By using a custom-made bioreactor, we can develop a homogenous 
sample of tissue, while also improving seeding efficiency, mechanically stimulating 
cells, and overcoming diffusional limitations present in static culture. This thesis will 
further investigate the feasibility of a “bone bank” that was investigated by Stace 
2011 (40). Similar to blood banking, bone banking will involve the storage of tissue 
for future use. This will assist those at risk of bone damage and disease, including but 
not limited to: soldiers, athletes, elderly and congenital defects such as cleft palate. 
 
The aims of this study were: 
1. To manufacture a structurally appropriate and biocompatible chitosan 
and hydroxyapatite scaffold. 
2. The generation of osteoid tissue, by three-dimensional cell culture of cells 





2 Literature Review 
 
2.1 Overview 
This literature review encompasses four main sections. The first section examines 
bone biology, its structure and function so we can apply this knowledge to bone tissue 
engineering (BTE). The second section examines various ways of bone regeneration 
with both intrinsic and extrinsic elements. And the third section focuses on BTE and 
its various components: cells, scaffolds and bioreactors.  
 
2.2 Bone Tissue 
 
2.2.1 Overview 
Bone is a specialized connective tissue that serves the functions of locomotion, 
protection and metabolic functions (7). There are three main cells present in bone 
tissue: osteoblasts, osteocytes and osteoclasts (8) within an extracellular matrix 
(ECM) called osteoid that is dominated with fibrillar proteins, providing a flexible 
trait. Upon the deposition of hydroxyapatite the osteoid becomes mineralized, 
providing properties of rigidity and strength (8).  
 
2.2.2 Structural Organisation 
The architecture of bone is organized for maximal strength and the lowest possible 
weight. The majority of bone has a dense, rigid exterior of compact (cortical) bone, 
and an interior of cancellous (spongy or trabecular) bone. There are two types of 
bone: woven, which is immature osteoid with disorganized collagen fibres; and 
lamellar, where collagen is arranged in sheets organized into regular parallel bands 
arranged in sheets (8).  Lamellar bone is considered to be mature or adult bone (7). 
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Compact bone is predominantly strong along the diaphysis and becomes 
progressively thinner towards the metaphysis and epiphysis (7). It is composed of 
units called osteons that are columns arranged in parallel to the line of stress applied 
to bone. Each individual column is made up of concentric bony layers, or lamellae, 
arranged around a Harversian (central) canal that contains neural and vascular 
elements. Osteons are produced by osteoclasts breaking down cortical bone to form a 
canal that blood vessels, lymphatics and nerves penetrate. Osteoblasts internally line 
this canal and begin producing lamellae.  After deposition of a series of lamellae, the 
diameter of the Harversian canal decreases and osteoblasts are trapped in lacunae to 
become osteocytes. Small canals called canaliculi interconnect other lacunae and 
contain cytoplasmic processes of trapped osteocytes. Volkman canals interconnect the 
neurovascular bundles within each Harversian canal (8). Compact bone is highly 
mineralized (up to 90%) allowing it to achieve its mechanical requirements (7). 
 
Cancellous bone consists of myriads of highly interconnected bony trabeculae and is 
mostly apparent in the epiphysis of bone. The trabeculae number, thickness and 
orientation depend on how stress is applied to bone. For example, there are thick 
intersecting trabeculae in weight bearing bone such as vertebrae, but fewer in ribs as 
they are exposed to less stress. Trabeculae are composed of lamellar bone with scanty 
lacunae containing osteocytes. Nutrient exchange occurs by canaliculi, with blood 
sinusoids in the marrow space that also allows osteocyte communication with one 
another.  The interior of the trabecular surface has a coating of endosteum with 
inactive osteoblasts. Cancellous bone, in contrast with compact bone, is only 20% 
mineralized. The other 80% of bone is covered by marrow, vasculature and stem 
cells. This allows it to achieve its metabolic function by allowing high communication 
between bone and other tissue (7). Spaces in the cancellous bone trabeculae contain 
haematopoietic bone marrow (8). 
 
2.2.3 Extracellular Matrix 
The extracellular matrix of bone is called osteoid and consists of organic and 
inorganic portions. Inorganic salts make up approximately 70% whilst organic matrix 
makes up the remaining 30% of bone (8).  
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Collagen almost makes up the entirety of the organic component at 90%, with the 
remaining 10% made by ground substance proteoglycans and non-collagen molecules 
(8). Collagen in bone is predominantly in the form of type I fibres, that follow specific 
directions to form the basis of the lamellar structure of bone (7). The ground 
substance serves to control water content in bone and regulate the formation of 
collagen fibres (8). The non-collagenous proteins, such as osteocalcin, osteopontin, 
and fetuin serve to balance mineralization by inhibition and exert important metabolic 
functions, such as control of energy metabolism by osteocalcin (7). Osteonectin 
provides a bridging function between collagen, mineral component and bone 
sialoproteins (8). 
 
The inorganic matrix serves as an ion reservoir. Ions form crystalline structures 
predominantly in the form of calcium hydroxyapatite (Ca10[(PO4)6(OH2)]) in ‘hole 
regions’ of the triple helical fibrils of collagen I. The addition of minerals to bone is 
controlled by non-collagenous proteins to balance flexibility and stiffness 
requirements (9,10). Hydroxyapatite formation occurs in membrane-bound vesicles 
secreted by osteoblasts, which accumulate calcium and phosphate ions. The vesicles 
ultimately rupture and hydroxyapatite crystals spill into the extracellular fluid to 
become part of the extracellular matrix.  The alkaline phosphatase enzyme secreted by 
osteoblasts cleaves large phosphate molecules (such as the mineralization inhibitor 
pyrophosphate) to individual inorganic phosphate ions, removing inhibition and 
further increasing phosphate concentration (10). Around 20% of the mineral 
component remains in an amorphous form, allowing the rapid exchange of ions for 
calcium homeostasis (8). 
 
2.2.4 Cellular Structure 
Bone cells develop from mesenchymal stem cells (MSC) or haematopoietic stem cells 
(HSC), to give rise to the principle cells that produce bone (osteoblasts), resorb bone 
(osteoclasts) and other cells associated with bone formation such as osteocytes, 
osteoprogenitor cells, and other bone lining cells (9). Osteoblasts and osteoclasts are 
important for the constant turnover and remodelling of bone (8). 
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Osteoblasts are cuboid-shaped cells that form clusters over a bone surface. They 
synthesize and excrete collagenous and non-collagenous bone matrix proteins onto 
bone before becoming either bone lining cells or trapped as osteocytes (7,9). This new 
non-mineralized matrix is called osteoid and takes about 10 days to be mineralized 
(7). Osteoblasts develop locally from MSC proliferation in bone marrow and 
periosteum. Differentiation is dependent on two key transcription factors, Runx2 and 
its target Osterix 1, which cause the differentiation of MSCs into osteoblasts in 
response to various stimuli, such as bone morphogenic proteins (BMPs) and 
parathyroid hormone (PTH) (7). 
 
Osteoclasts are large, multinucleate cells containing up to 20 nuclei and have the 
unique ability to resorb bone. They have a characteristic ‘ruffed border’, which is a 
highly folded plasma membrane designed to secrete and resorb proteins and ions into 
an isolated space where bone resorption occurs. This region is sealed by contractile 
proteins and tight junctions to localize the acidity (7). Energy demanding proton 
pumps acidify the contained region to mobilize the mineralized bone. The remaining 
organic matrix is subsequently broken down with proteases. This results in Howship’s 
lacunae, a characteristic shallow cavity. Osteoclasts are derived from HSCs that have 
generated mononuclear cells, which further develop into preosteoclasts that leave into 
the blood. These cells leave the circulation at sites that require resorption and fuse 
with one another to form a multinucleated immature osteoclast. Mature osteoclasts are 
differentiated from immature osteoclasts by attachment to bone matrix by integrins 
(9).  
 
The most numerous cells are osteocytes and are found in lacunae throughout the 
matrix. Osteocytes develop from osteoblasts that are trapped in bone matrix during 
bone formation (7). Lacunae are interconnected by canaliculi where osteocyte 
cytoplasmic processes pass through. Neighboring osteocytes communicate via gap 
junctions to convey intracellular messages, and for nutrient transport. Their principal 
role appears to be the sensing of mechanical stimuli, to regulate bone remodelling and 
development in response to shear or strain forces. Their possible role in calcium and 
phosphate homeostasis remains unclear (9,11). 
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The endosteum is the inner surface of compact bone, whereas the periosteum is a 
layer of condensed fibrous tissue covering the outer aspect of bone. Both contain 
osteoprogenitor cells that are activated for healing and remodelling (7,8). These 
processes will be discussed in more detail in 2.2.6 and 2.2.7. 
 
2.2.5 Bone Development 
Bone development occurs by two main processes, intramembranous and 
endochondral ossification. Intramembranous ossification forms flat bones. It is the 
formation of primary ossification centers by MSCs that have differentiated into 
osteoblasts, which directly produce osteoid. These centers then fuse to form an 
interconnected network of trabeculae made of woven bone. The periosteum forms on 
the surface, further mineralization occurs and the connective tissue within the 
trabeculae is transformed into haematopoietic tissue. Remodelling finally follows to 
produce lamellar bone. Endochondral ossification occurs in long bones, pelvis and 
sacrum and is the ossification of cartilage that is produced by chondrocytes that have 
differentiated from MSCs.  Hypertrophic chondrocytes release various molecules that 
promote vascularization and primary ossification, calcifying cartilage. Secondary 




Growth, maintenance, and regeneration of bone involve the high regulation of 
mechanical integrity and calcium metabolism. Bone remodelling is dynamic, occurs 
continuously throughout life and consists of bone resorption coupled with 
simultaneous formation (7,13). It is tightly controlled by a complex arrangement and 
number of cell types including osteoblasts, osteoclasts and osteocytes, which are 
collectively called basic multicellular units (BMUs) (14). Remodelling occurs in 
response to mechanical forces, microdamage and systemic hormones, that are likely 
sensed by osteocytes to initiate remodelling at a specific site. This mostly occurs in 
cancellous bone, building an optimum architecture to adapt to an individual’s 
demands (7), to obtain maximum strength with minimal weight (14). Wolff’s Law 
directs remodelling. If a mechanical force is exerted onto bone, bone will remodel 
itself to resist that loading (15). Coupling, the phenomenon of tight regulation of 
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resorption and formation is regulated on three different levels: direct interaction 
between osteoblasts and osteoclasts, local interactions between the immune system 
and bone cells, and neuroendocrine systemic factors that control bone metabolism (7). 
This ensures that removed bone is always replaced by new bone (9). 
 
2.2.7 Regeneration 
Fractures are one of the most common injuries to the musculoskeletal system (16). In 
response to injury, bone heals by regeneration instead of repair. This allows tissue and 
mechanical properties to be restored at the site of injury, allowing bone to continue 
meeting its mechanical demands (9).  
 
There are two types of bone healing: primary and secondary. Primary, or direct 
healing requires fracture ends to be rigidly fixed and immobile by early orthopedic 
intervention (9). This allows the omission of an external callus for stability. 
Osteoclasts tunnel into bone, allowing blood vessel penetration and osteoblast 
precursor recruitment, creating new osteons that connect ends of the fracture. Primary 
bone healing is the synthesis of lamellar bone in the same direction as the bone’s 
longitudinal axis (9). This type of healing is slow and considerable time is necessary 
for the healed fracture to weight bear after the removal of the orthopedic interventions 
(16). 
 
Secondary, or indirect healing is more frequent (9). The fracture is stabilized using 
plaster of Paris, braces, and external fixators or bridging plates. These allow 
considerable movement and stimulate the development of a soft callus. Secondary 
healing has three overlapping steps: inflammation, reparation, and remodelling (16).  
A fracture results in a hematoma, a hemorrhage that is infiltrated by neutrophils and 
macrophages, and marks the start of inflammation. This initiates angiogenesis, 
chemotaxis of neutrophils, exudation of plasma, and fibroblast synthesis of collagen, 
which form granulation tissue that replaces the hematoma (9,16). The reparative 
phase involves osteoprogenitor cells of the periosteum to differentiate into cartilage 
producing chondroblasts, and osteoblasts that synthesize woven bone. The fibroblasts 
within the granulation tissue can also differentiate into chondroblasts. The product of 
these cells produces a mass called a primary callus; this stabilizes the fracture site and 
 9 
favors bone formation. Once completed, this process is called clinical union. 
Osteogenesis then dominates to transform the primary callus to a secondary callus. 
The final stage, remodelling of woven bone to lamellar bone is necessary to produce 
mature bone (9).  
 
In non-unions, healing stops with no attempt to bridge the fracture with a callus; 
instead it is replaced with fibrous tissue. Certain factors can cause a fibrous non-union 
including: infection, avascular supply, shearing forces, loss of apposition and disease 
(such as tumors). Radiographic imaging shows bone ends become round and dense 
compared to fresh fractures that are clear-cut (17). 
 
Fractures are usually reduced and fixed to enhance healing. Reduction is the 
procedure of restoring a fracture or dislocation back to its correct alignment. Fixation 
provides stability and maintains alignment of bone fragments during healing. It may 
be by a plaster of Paris cast, or internal fixation, where surgery is required to implant 
an internal fixator made of inert metal. It may also be external fixation where metal 
stabilizes the fracture at a distance from the injury (17,18).  
 
For an organ that often heals itself, bone can have difficulty regenerating. For many 
fractures and bone defects, orthopedic intervention is not enough to initiate healing as 
it had resulted in a critical size defect (CSD). The concept of a CSD is based on the 
observation that defects of a certain size will not heal spontaneously in the lifetime of 
the animal (19,20). The gold standard treatment of CSD is autologous bone grafts 
(20), however, as with all treatments comes with disadvantage, which will be 
explained in 2.3.4.1. Considerable research focuses on four areas: non-unions, spinal 
fusion, calvarial and long bone CSDs (19). Problematic healing is currently being 
investigated, using scaffolds and mesenchymal stem cells for tissue engineering 
(19,20). 
 
2.2.8 Cellular Communication 
As before in 2.2.6, bone remodelling constantly alters bone structure throughout life. 
Other than the systemic factors that influence this, there are also local paracrine 
factors that allow cross talk between osteoblasts and osteoclasts (21). Osteocyte death 
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by senescence is sensed by osteoblasts that are under regulation of osteocyte-secreted 
sclerostin (21,22). Direct cell-cell communication occurs by osteocyte-osteoblast gap 
junctions that may sense this cell death. Osteoblasts attract osteoclast precursors to the 
area and stimulate osteoclastogenesis (22). Adhesion molecules Ephs and Ephrins are 
expressed on the osteoblast cell surface for direct cell-to-cell contact with osteoclasts 
and may play a role in osteoclast precursor migration (21,22). Simultaneous 
expression of differentiation factors such as RANKL by osteoblasts induces 
osteoclastogenesis. Cell-cell communication between preosteoclasts cells results in 
cell proliferation and fusion. Sema4D from osteoclasts inhibits bone formation by 
osteoblasts (21). After an area is resorbed, osteoclasts die by apoptosis and osteoblasts 
secrete new bone tissue (22). There is also cross talk between cells of the immune 
system that also regulates bone remodelling (21).  
 
2.3 Bone Grafting  
2.3.1 Overview  
Bone loss due to disease or trauma can lead to premature disability and lowered 
quality of life (23).  Bone grafts are widely used and help promote bone formation 
and regeneration. They function partly as scaffolds for osteoconduction, matrices for 
attachment and induce the proliferation of osteoblasts that require anchoring, and sites 
of intrinsic bone formation through osteogenesis (24). There are four different types 
of bone grafts: autografts, allografts, alloplasts and xenografts (23). 
 
2.3.2 Indications and Contraindications 
Indications for autologous bone grafting are reconstruction of skeletal defects that 
includes: tumors, trauma, infections, augmentation for fracture healing, delayed-
union, mal-union, non-union, joint fusion, reconstruction, and prevention of 
morbidities in patients with risk factors (such as diabetes and smoking). 
Contraindications include limiting supply due to previous surgery, an active infection, 




There are three biologically important properties that form the foundation for bone 
grafting: osteoconduction, osteoinduction and osteogenesis.  
 
2.3.3.1 Osteoconduction 
Osteoconduction, defined as the ability of the graft to support osteoblast formation of 
new bone along a biological or alloplastic framework, with a porous matrix to support 
migration, attachment and proliferation of cells (5,26). This property is shown by 
autografts, allografts and many bone substitutes (24,27). 
 
2.3.3.2 Osteoinduction 
Osteoinduction is the enhancement of bone formation by the stimulation of 
osteoprogenitor cells to differentiate to osteoblasts (24,27).  And therefore stimulating 
osteogenesis (28). The gold standard autograft displays this attribute, but 
complications and lack of supply have lead to the research of many growth factors to 
mediate bone formation. An osteoconductive and osteoinductive graft not only acts as 
a scaffold, but also stimulates new osteoblast formation; this is desirable as it allows 
faster graft integration (24,27). 
 
2.3.3.3 Osteogenesis 
Osteogenesis is simply bone formation from osteoprogenitor cells where bone can be 
produced spontaneously or transplanted (28). Surviving cells in the graft can produce 
new bone. Because of limited supply of gold standard autografts, significant research 
in BTE is a promising field to provide bone grafts for defects. Osteogenesis occurs in 
autografts only (24,27).  
 
2.3.3.4 Other Properties 
Mechanical properties are necessary for weight bearing and are employed by 
autografts and allografts. Grafts should have other desirable properties such as being: 
biocompatible, integrating with neighboring tissue without eliciting an immune 
response; biodegradable, metabolised by the body to be replaced by host tissue and 
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not release toxic breakdown products; and bioactive, promoting osteointegration and 
stimulating bone ingrowth and differentiation (23). 
 
2.3.4 Graft Structure and Uses 
Grafts can be classified as cortical, cancellous, or cortiocancellous depending on the 
structure present. Bone varies in structure depending on where it is harvested from, 
and thus, also varies in their ability to provide structural support and osteogenesis. 
Cortical bone grafts are used for stability and support and is replaced much slower 
than cancellous bone grafts. Cancellous bone grafts are more osteogenic, however it 
cannot provide efficient structural support, therefore bone grafts needs to be carefully 
selected for a specific function before harvesting (27). Mixed properties may be 
obtained from a single graft (24). 
 
2.3.5 Types of Grafts 
Currently, bone grafts to be used as substitutes come from many sources. These are 
autografts, allografts, alloplasts and xenografts (23).   
 
2.3.5.1 Autograft 
An autograft (also known as an autologous and autogenous graft) is when bone is 
moved from one site of the body to another within the same individual (24) and is the 
gold standard for bone grafting (29). As these grafts are from the same patient, it is 
non-immunogenic, and has the properties necessary for healing: osteogenic, 
osteoconductive and osteoinductive. However, they have several disadvantages such 
as limited supply, post-operative complications, anatomical incompatibilities and 
donor site morbidity, as the anterior iliac crest is the most common site for harvesting 
bone (23,25,30). The quality of these grafts can also be adversely affected by the 
patient’s comorbidities and age (25). All bone requires blood supply in the site of 
implantation. Additional blood supply may be needed; this is done by extraction of 





An allograft is tissue transferred from one individual to another of the same species 
(24). It is usually taken from cadavers who have donated bone and is typically 
sourced from a bone bank (27). The structure of the allograft provides an 
osteoconductive scaffold for fibrovascular growth and attraction of cells from the host 
that eventually leads to bone development (29). To prevent disease and 
immunogenicity, donor screening and tissue processing is required. The graft can be 
freeze-dried, demineralized and irradiated, which is disadvantageous as the bone will 
lose osteogenic potential, osteoinductive properties and integrity (4,31,32). 
Chemosterilized, autolyzed, and antigen-extracted bone weakens strength and 
integrity, but leaves osteoinduction intact (4). Because of this processing, allografts 
are used mostly for filling skeletal defect cavities (4).  
 
Advantages of this graft is that there is a large supply and no donor site morbidity 
(32). Failure of allografts is higher compared to autografts, which is due to 
immunogenic properties. The major histocompatibility complexes (MHC) I and II 
antigens on the graft are recognized by T-lymphocytes, resulting in immune rejection 
of the graft by cell-mediated toxicity, antibody-mediated toxicity, and antibody-
dependent cell-mediated toxicity. To reduce immunogenicity, tissues can be modified 
as mentioned above and host can be matched to donor (4).   
 
2.3.5.3 Alloplast 
Alloplasts (or synthetic materials) are biocompatible, inorganic materials that are 
widely used due to osteoconduction, strength and incorporation into bone.  These can 
be used as cancellous bone substitutes or fillers, where structural stability is not 
necessary. These materials are porous for cell and vessel invasion, and are eventually 
replaced by new bone (27,32). The advantage of these materials is that there is no risk 
of disease transmission and it can be mixed with autografts or allografts (32). 
Alloplasts can be bioinert, where there is no adherence to tissue in the implantation 
site. They can be bioactive, chemically reacting to surrounding tissue to form a strong 
bond. They can be bioresorbable, where the material contributes to the metabolic 
processes of the host to regenerate the tissue (33). Bone is a composite material, made 
of an organic and an inorganic component, providing flexibility and strength 
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respectively. Current work is looking into the development of new hybrid materials 
with combined properties of several materials, with focus on hydroxyapatite (HA) as 
the inorganic component (34,35). 
 
2.3.5.3.1 Ceramics 
Ceramic-based materials constitute a large proportion of materials for restoring bone 
defects and can be mixed with other graft material or used alone. They are very 
similar to the inorganic matrix of bone and are osteoconductive. They are not 
osteoinductive, as new bone is not stimulated and they are used best for filling 
contour defects (31). The ideal alloplasts are resorbable into the body and have 
similar strength to cancellous bone (29). Ceramic-based substitutes include, but are 
not limited to: calcium phosphate, calcium sulfate, and bioglass. These can be used 
alone or in combination.  The pore size of ceramics should be similar to cancellous 
bone to allow fluid circulation and cell colonization (36). 
 
HA is a crystalline structure of calcium phosphate with the chemical formula 
Ca10(PO4)6(OH2) (29). Natural HA makes up the majority of the mineral phase of 
bone (37). Synthetic HA has a similar chemical makeup to human hard tissue 
allowing a favorable chemical and biological affinity to bone tissue (37,38). Due to 
these similar chemical properties with mineralized bone matrices, HA provides 
excellent osteoconductive, bioactive and biocompatible properties (29,36,38). 
Although hydroxyapatite has good cytocompability, disadvantages include low 
solubility in physiological pH and differing mechanical properties from bone (36). 
Despite these, HA is accepted as a widely used biomaterial for bone regeneration 
(37).  
 
Nano-hydroxyapatite (nHA) is stable in normal temperatures and pH and is poorly 
soluble in water. Additionally, it has a high hardness, bioactivity, no cytotoxic 
properties and is biocompatable with skin, muscle and hard tissues. The application of 
nHA to bone during bone implantation results in rapid bone formation and a solid 
biological fixation to bone due to its osteoconductive and bioactive properties  (33). 
nHA has a similar structure to the minerals found in bone and is thought to enhance 
the mechanical and osteoconductive properties of implants. Compared to micro-
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hydroxyapatite (µHA), nHA has a high surface area to volume ratio that could control 
protein interactions (adsorption, configuration and bioactivity) and therefore enhance 
osteoblast adhesion (37). 
 
Tri-calcium phosphate is also a biocompatible crystalline structure like HA with the 
formula Ca3(PO4)2. Its structure is similar to the mineral phase of bone with higher 
degradation rates compared to HA, which occurs by dissolution and resorption by 
osteoclasts. Osteoconduction is improved by small particle size and an interconnected 
sponge-like matrix that allows fibrovascular invasion and bone production (29,36). 
Calcium phosphate cements are also available with the advantage of changing shape 
required for the bony defect. The disadvantages of cements include the requirement 
for close contact with bone for osteoconduction and a lack of a porous matrix for 
tissue invasion (36). 
 
Bioactive glass is biocompatible, resorbable, osteoconductive and bonds to bone 
without fibrous tissue. It is made of silica, sodium oxide, calcium oxide and 
phosphate. The surface of bioactive glass is apatite and is replaced by bone – the bone 
bonding response (36). This is dependent on the silica content and results in a strong 
bond that later results in a strong integrative response to generate an osteoconductive 
location (29). Biocompatibility is shown by the absence of inflammatory infiltrate.  
The chemical reaction of bioactive glass is dependent on temperature, pH and the 
surface layer. Its porous network provides an osteoinductive scaffold and also helps 
resorption and bioactivity (36). Disadvantages of bioglass include little structural 
integrity (29). 
 
Calcium sulfate functions as an osteoconductive bone filler that is completely 
resorbed, restoring anatomic features and structural properties (29). There is 
significant loss of weight bearing properties during degradation, hence should not be 
used for structural integrity (36).  
 
2.3.5.3.2 Implantable Metals 
The use of inert metals as pins, screws or plates are used for fracture stabilization. 
Stainless steel and titanium are most frequently used. Disadvantages of these include 
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stress shielding, inflammatory osteolysis, interference with radiological studies, and 
are permanent unless removed. Removal provides additional surgical related risks 
including infection and morbidity (39,40). While providing structural integrity, 
biodegradable metals degrade over time and thus leave no disadvantages associated 
with permanent inert metals. For example, magnesium alloys are biocompatible, non-
toxic, and provides appropriate structural integrity (39,40). Disadvantages include 
unequal degradation rates to that of bone formation. This may be altered by 
combining metals with other materials (39). 
 
2.3.5.3.3 Biodegradable Polymers 
Implantable polymers, which can be natural or synthetic, have appropriate properties 
for cell attachment and growth. They are described as biocompatible, with some being 
biodegradable with modifiable degradation rates. The body resorbs degradable 
polymers, which is advantageous as healing can occur without leaving any material 
behind. The physical properties of polymers can be disadvantageous, such as limited 
mechanical properties, processability and variability between batches. They can be 
used alone or mixed with other materials in order to improve mechanical properties 
and processing (36).  
 
2.3.5.4 Xenografts 
Xenografts are grafts from another species, such as bovine. In order to reduce the risk 
of disease transmission it must be deproteinized, leaving only a calcified matrix of 
non-vital bone (12,27). Advantages and disadvantages of xenografts are similar to that 
to processed allografts (32). 
 
2.3.6 Obtaining Grafts 
Autografts are indicated for most applications with other types of bone grafts 
indicated if autograft supply is not enough or unattainable. Cancellous grafts can be 
obtained from superficial sites by surgery. These include: the greater trochanter, 
femoral condyle, medial malleolus, olecranon, distal radius, and the proximal 
metaphysis of the tibia. Larger cancellous and corticocancellous grafts can be 
contained from the anterior superior iliac crest and posterior iliac crest. Cancellous 
 17 
grafts can also be obtained from the trabecular cavity during reaming procedures (24).  
Whole bone grafts can be obtained from the fibula (27). 
 
2.4 Bone Tissue Engineering 
 
2.4.1 Overview 
Tissue Engineering is “an interdisciplinary field of research that applies the principles 
of engineering and life sciences towards development of biological substitutes to 
restore, maintain or improve tissue function” (41). The concept requires four key 
factors: a biocompatible scaffold similar to bone ECM, osteogenic cells to synthesize 
bone tissue, morphogenic signals to assist cells to differentiate to the desired 
phenotype and sufficient vascularization for nutrient and waste exchange (42)  
 
2.4.2 Strategies 
There have been different BTE methods that can be classified into two categories: cell 
or growth factor based strategies. Both provide an environment of bone regeneration 
by the introduction of osteogenic cells onto a 3D scaffold (41). However, cell-based 
strategy combines osteogenic cells with biomaterial scaffolds ex vivo, while relying 
on growth factors from the repair site to stimulate regeneration. Growth factor-based 
strategies rely on growth factors for an osteoinductive effect to recruit osteogenic 
cells from the local site (41,43). A cell-based strategy works independently of local 
osteogenic cells, and thus is an attractive approach for patients that have little to no 
osteogenic cells, including those with trauma, diabetes, and osteoporosis. Further 
more, recruited cells release growth factors at physiological doses allowing a more 
effective bone regeneration. In contrast to growth factor-based strategy, there is 
difficulty determining the optimal dose of growth factor for large animals, and 
delivery and release of the factor into the circulation (41). Supraphysiological doses 
are sometimes necessary for an osteoconductive effect (43). 
 
2.4.3 Osteogenic Cells and Cells with Osteogenic Potential 
A cell-based approach for bone regeneration is effective and assists in recruiting 
progenitor cells during the early stages of repair. The mechanisms that bone 
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regeneration occurs in BTE are: early release of osteogenic, vasculogenic molecules 
and growth factors, template formation for cell recruitment, and bone matrix synthesis 
and vascularization of the construct. Cell types come from many sources including 
mesenchymal, embryonic, induced-pluripotent, adipose-derived, and human 
exfoliated deciduous teeth (SHED) stem cells. For successful graft incorporation and 
healing the properties of the cell must include: isolation and expansion efficiency, 
expression and stability of bone markers and bone formation (42).  Only osteogenic 
sarcoma cell line (SAOS-2) and mesenchymal stem cells (MSCs) will be discussed in 
this review as these are the pre-determined cells of choice. 
 
2.4.3.1 Osteogenic Sarcoma Cell Line  
The SAOS-2 cell line was isolated and characterized by J. Fogh and G. Trempe from 
an 11 year old Caucasian girl in 1973 (44). It was derived from a malignant bone 
tumor that shares several features with osteoblastic cells that makes them commonly 
used as osteoblastic models (45). Features which make SAOS-2 appropriate as an 
osteoblastic model include: generation of a mineralized ECM, a strong alkaline 
phosphatase (ALP) reaction, PTH and vitamin D reaction, and the presence of bone 
matrix proteins (46). 
 
2.4.3.2 Mesenchymal Stem Cells 
MSCs are multipotent stem cells that can differentiate into multiple lineages including 
osteoblast, chondroblast and adipocyte (47).  Under appropriate stimuli (such as 
injury) MSCs can differentiate as required for tissue repair (48). MSCs have 
recognized potential for BTE as they are involved in natural bone development and 
have been widely used with many biodegradable scaffolds (42,49).  
 
They come from many sources including: bone marrow, peripheral blood, umbilical 
blood, synovium, deciduous teeth, tooth pulp, amniotic fluid, adipose, brain, skin, 
heart, kidneys and liver (42). They are mostly isolated through a bone marrow 
aspirate procedure (6), are easily expanded in culture to give rise to distinct colonies 
(50), and are non-immunogenic (41,47). With a bone marrow aspirate, there are only 
a small number of MSCs, therefore cells must be expanded but this may affect 
differentiation capacity (49). Bone marrow aspirate concentrates are commonly 
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isolated from a patient’s iliac crest and are an excellent source of osteogenic stem 
cells and osteoconductive growth factors for bone regeneration. Aspirates specifically 
contain MSCs, endothelial progenitor cells (EPCs), HSCs, platelets, lymphocytes and 
granulocytes and all have a necessary role in bone regeneration (42). With the ability 
of high proliferative rates and resistance to freeze damage they can be expanded in 
vitro to acquire cell numbers of choice. MSCs express various markers that allow 
definition (42). 
 
MSCs are described to be fibroblastoid, a spindle-shaped morphology (48,50,51), and 
have the ability to adhere to tissue culture plastic (42,50). Efficiency of colony 
formation and culture conditions vary between species, which depend on a number of 
factors such as fetal bovine serum (FBS) (50). MSCs also secrete cytokines and 
growth factors that influence differentiation and aging of other cells in the body. They 
can also invade and migrate through ECM to create important cell transpositions (48).  
 
To enhance bone regeneration, MSCs are stimulated to differentiate down the 
osteogenic lineage.  The 3D scaffold may be imbedded with osteogenic growth 
factors that also stimulate the migration and differentiation of progenitor cells. 
Differentiation to osteoblastic cells before implantation is shown to assist repair as the 
mature osteogenic cell population can immediately synthesize bone (42). MSCs do 
not spontaneously differentiate in culture. After expansion, differentiation requires 
appropriate culture conditions and/or induction agents such as fibroblastic growth 
factor (FGF-2), transforming growth factor beta (TGF-β), and bone morphogenetic 
protein two (BMP-2) (42,47).   
 
There are several disadvantages using MSCs. Studies show that there is a maximum 
of 24-40 population doublings until senescence is reached. With increasing donor age 
and systemic disease, osteogenic differentiation in vitro and in vivo significantly 
decreases (42).  
 
2.4.4 Three-Dimensional Scaffold 
Scaffolds are a support, delivery vehicle, or matrix to facilitate migration, binding, or 
transport of cells and/or bioactive molecules used to replace, repair, or regenerate 
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tissue (5). The ECM is important to tissues as it regulates cellular activity. Bone 
cannot grow in a 3D manner in vitro; therefore a 3D structure that mimics the ECM 
supports growth of new bone tissue. This scaffold provides a temporary environment 
for cell attachment, migration, proliferation, differentiation and ECM deposition 
(6,12,26). As described before, factors that assist bone regeneration in tissue 
engineering include: osteoconductivity, a porous matrix for cell attachment, 
migration, proliferation and neovascularization; osteoinductivity, possession of 
proteins and growth factors for inducing surrounding MSCs to differentiate to the 
osteoblastic cell lineage; osteogenecity, osteoblasts present at the site of new bone 
formation produce osteoid; and osteointegration, mineralized tissue can bond to 
implant material (5,26). 
 
When implanted it becomes vascularized and integrated into host bone. Scaffolds 
should be biocompatible, not evoking an immune response when implanted and 
invoke a healing or physiological inflammatory response (12). The scaffold should be 
able to transfer load to surrounding tissue, mechanically strengthen the implantation 
site after insertion and also resist physiological loading (6). 
 
Adequate interconnected pores within a scaffold are required for osteogenesis and 
vascularization as this allows nutrient, metabolite and waste exchange, avoiding 
hypoxia and necrosis (52,53).  An interconnected matrix promotes cell growth and 
distribution throughout the matrix (12). There have been various studies that research 
the optimal pore size of the scaffold material. A summary of pore sizes and their 
associated characteristics are found below in Table 2.1. There is an upper limit for 
increasing porosity as this results in reduced mechanical and compressive strength 
that is essential for weight-bearing bones (12,53,54). Increasing porosity with 




Table 2.1: Pore Sizes and Associated Characteristics. The pore size (µm) for scaffolds provides 
various factors for three-dimensional cell culture. 
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Pore size (µm) Characteristics Reference 
96 -150 Cell attachment Murphy & O’Brien 2010 
100 – 150 Cell size, migration and fluid 
transport 
Bose et al., 2012; Costa-Pinto et 
al., 2011; Murphy & O’Brien, 
2010 
200 - 350 Optimal Osteogenesis Bose et al., 2012 
200 – 500 Vascular ingrowth Meyer et al., 2010 
300 – 800 Osteogenesis and 
vascularization 
Murphy & O’Brien 2010 
 
 
Degradation should occur at a rate similar to the formation of new tissue without 
releasing toxic products and changing the pH of the local environment (5,26). 
Manipulating chemical and physical properties of the scaffold can alter degradation 
rate (55). 
 
An approach for the fabrication of 3D scaffolds is using a naturally occurring 
substance such as natural polymers. They may have different functions in their 
original environment, but they are found to be biocompatible and have modifiable 
biodegradable rates. Further information about polymers was discussed in 2.3.5.3.3 




Chitosan (CS) has shown excellent properties for being a suitable biomaterial for 
BTE. It is a linear polysaccharide that is obtained from deacetylated chitin (an 
aminopolysaccharide found in the exoskeletons of crustaceans) (36,56). The polymer 
chain is made of glucosamine and N-acetyl glucosamine with β-1,4 linkages (57).  
When N-acetyl glucosamine units are greater than 50%, the polymer is chitin. When 
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the number of N-glucosamine units is superior, it is CS (56). The degree of CS 
deacetylation ranges from 40-98% (57). Molecular weight is dependent on origin and 
preparation and ranges 5x104 and 2x106 Da. The degree of acetylation and 
polymerization determines the molecular weight of CS and thus, are important factors 
for its various uses (57). Solubility of chitosan is dependent on the free amino and N-
acetyl groups that are soluble in an acidic pH (56,57).  
 
CS has a highly cationic nature allowing its use it many biological applications as a 
biomaterial, giving it the properties of bioadhesion, increased absorption, transfection 
efficiency, anti-hypercholesterolemic, anti-microbial, anti-inflammatory and anti-
tumor effects (56,57). 
 
With bioadhesive properties, it can interact with anionic glycosaminoglycans (GAGs) 
and proteoglycans. Interactions with GAGs are important as cytokines and growth 
factor action can be altered. Antimicrobial properties are thought to be due to CS’s 
cationic nature disrupting cell wall synthesis, structure and cellular transport (56). CS 
has additional properties that make it an appropriate biomaterial for BTE: 
biodegradable, accelerated healing and biocompatible (56). Degradation of CS can 
occur by chitosanases, which are absent in mammals, so the majority of degradation 
occurs by lysozymes. Degradation, similar to CS’s other properties is also dependent 
on the degree of deacetylation. Wound healing properties are due to macrophage 
activation and the production of cytokines. This accelerates healing while also 
protecting against infection (56). CS has excellent biocompatibility with tissue with 
no pathological inflammatory response (58). 
 
CS can be molded into various structures depending on usage, including 
microspheres, paste, membranes, sponges, fibres, and porous scaffolds (12,56). CS is 
mechanically weak and lacks bioactivity (56) therefore load bearing applications are 
limited. These disadvantages can be overcome by combining CS with bioactive, 
mechanically strong materials such as hydroxyapatite (59).  
2.4.4.1.1 Freezing and Lyophilization of Chitosan Scaffolds 
CS scaffolds can be produced by freezing and subsequent lyophilization (freeze-
drying). In a process called phase separation, the freezing of a CS solution causes the 
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formation of ice crystals, and the simultaneous precipitation of CS that surrounds 
them. Water diffuses to developing crystals and causes growth with respect to size. 
Freeze-drying the ice crystal will leave a space (pore) surrounded by precipitated CS.  
 
The surrounding thermal gradient during the freezing process plays a major role on 
whether pores will form. A large thermal gradient gives rise to a heat transfer 
governed system and causes water diffusion and ice crystal formation in the direction 
of the gradient, resulting in layered sheets. A small thermal gradient gives rise to a 
mass governed system and causes slower diffusion of water molecules to developing 
ice crystals, forming spheres growing in all directions. These spheres are freeze-dried 
to leave a pore. Ice remodels with time, these ice crystals become elongated and 
anneal in the direction of the thermal gradient (60,61). 
 
2.4.5 Morphogenic Signaling 
BMPs are a group of growth factors that belong to the TGF-ß superfamily (62). They 
have a strong effect on bone growth with important roles on early skeleton formation 
(63). BMP-2 can be used in various clinical applications including bone defects, non-
unions, spinal fusion, osteoporosis and root canal surgery due to powerful 
osteoinductive properties (62,63). Implantation of BMP-2 results in MSC infiltration, 
cartilage formation, vascularization, bone formation and remodelling of tissue (64).  
 
2.4.6 Bioreactors 
The bioreactor is a dynamic system used for in vitro culture (41). The use of a 
bioreactor to cultivate 3D scaffolds is used to achieve homogenous bone 
development. Three factors allow this: improved cell seeding efficiency, increased 
mechanical stimulation of osteogenic cells, and removing the diffusion mediated 
limitation of nutrient and waste exchange (41,42,65). Environmental factors such as: 
temperature, pH, pressure, nutrient supply and waste removal, can be manipulated for 
optimal cell growth (42,65). This allows automated and standardized tissue 
manufacturing, reducing production costs, and lead the way for industrial-scale 
production of BTE (42). The bioreactor should be composed of biologically inert and 
non-corrosive material to prevent release of toxins. It is usually made from synthetic 
polymers that can withstand sterilization techniques (65). 
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There are several types of bioreactors with different flow patterns that improve 
cellular proliferation and differentiation (41,42). These include stirred flasks, rotating 
bioreactors and perfusion bioreactors. Discussion will focus on perfusion bioreactors, 
as it is the pre-determined bioreactor for this thesis (42).  
 
Perfusion systems consists of a chamber that hosts the 3D scaffold, and a peristaltic 
roller pump to deliver culture medium, allowing laminar flow and mass transport of 
nutrients through the entirety of the scaffold (42,65). Fluid flow can be steady, 
oscillating or pulsatile with each significantly influencing osteogenic cells (42). 
Perfusion system studies show there is improved osteogenic cell distribution, density, 
proliferation, differentiation, and deposition of ECM through the entire scaffold in 
vitro (41,42), allowing improved bone growth in vivo compared to static culture 
systems. As bone tissue is mechanically sensitive, bioreactors can be designed to 
mechanically stimulate scaffolds. This is associated with increased ALP, mineralized 
matrix and osteogenic gene expression (42).  It was found that oscillating flow was 
less stimulatory than pulsing or steady fluid flow (65). Grayson et al. demonstrated 
that a linear velocity of 400–800 mm/s was optimal for their system based on 
histological analyses, connexin expression, and protein contents (66). A flow rate of 
0.01 to 3 mL/min has been shown to increase cell proliferation, mineralization and 
protein expression (67–69). 
 
Uniform and efficient seeding of cells is necessary for successful bone grafts as this 
results in homogenous distribution of cells and increases viability (42,70). Efficient 
seeding limits biopsy size, extent of cell expansions and is directly associated with 
bone mineralization. Increased cell density is associated with increased gene 
expression, differentiation and mineralization. Manual, static seeding of cells onto the 
scaffold is most commonly used, but has low seeding efficiency and non-uniform 
distribution. High efficiency and uniformity can be obtained using bioreactors for 
dynamic seeding. Perfusion bioreactors have the highest seeding efficiency and 
uniformity; dilute cell suspension flows through the pores and allows cell seeding 




In conclusion to this literature review, bone is an incredible connective tissue with a 
high potential for regeneration. Despite this, the occurrence of critical sized defects 
(due to the nature of the size of the bony wound) causes limitations in healing with 
consequential soft tissue formation and therefore, reduction of functions of 
locomotion and protection. The healing and reparation of CSDs are attempted in a 
variety of ways, such as the gold standard autografts and allografts, xenografts, and 
synthetic materials, with each having their own advantages and disadvantages 
(primarily concerned with availability, disease transmission, graft rejection, healing 
potential and surgical morbidity). Thus, there is demand for bone substitutes superior 
in all these aspects. Bone tissue engineering can solve the low availability and 
surgical morbidity of superior autografts, by isolating the patient’s stem cells by a 
bone marrow aspirate, differentiating them to bone-producing osteoblasts and 
combining them with a biocompatible scaffold for support in 3D culture. This 3D 
environment simulates physiological conditions for osteoid production, while using a 
bioreactor provides additional physiological factors such as shear force, and a 
simulated blood circulation by the constant supply of nutrients and removal of waste. 
Although further work needs to be done, 3D culture of osteoblasts on a scaffold has a 


















Pre-made α -minimal essential media (αMEM) and Dulbecco’s Modified eagle 
Medium (DMEM), Dulbecco’s Phosphate-Buffered Saline (DBPS), nano-
hydroxyapatite (nHA), and glacial acetic acid (~99% purity) were purchased from 
Sigma. Powdered media (αMEM and DMEM) and LIVE/DEAD® assay was 
purchased from Invitrogen. Anti-Anti (antibiotics and antimicotic solution), Fetal 
bovine serum (FBS), Trypsin with ethylenediaminetetraacetic acid (EDTA) and 
phosphate buffered saline (PBS) were purchased from Gibco. 80% deacetylated 
Chitosan powder was purchased from Wako. MTS cell proliferation assay was 
purchased from Promega. Pharmed BPT and Tygon 3350 tubing were purchased from 
Saint Gobain. Micro-hydroxyapatite was purchased from Acros Organics, Triton-X 

















3.2.1 Chitosan Scaffold Manufacture and Analysis 
 
3.2.1.1 Primary Chitosan Scaffold Manufacture 
3.2.1.1.1 Chitosan Scaffold Manufacture 
The first attempt of making scaffolds was as follows. 80% deacetylated chitosan (CS) 
powder was added to 1% (v/v) acetic acid (AA) to produce 0.5, 1.0, 1.5, 2.0 and 2.5% 
(w/v) solutions, as according to Table 3.1 below. The solutions were mixed on a plate 
shaker for 20 minutes or until dissolved so that there were no visible large particles of 
CS in solution. 5 mL of each solution was added to each well of a Corning® Costar® 6 
well cell culture plate (Sigma-Aldrich, USA) and left in a cool, dry place overnight to 
allow air bubbles that were incorporated during mixing to escape. Samples were then 
frozen at -80 °C for at least 24 hours.  
 
Table 3.1: Primary Chitosan Scaffold Protocol. Well number of 6 well culture dish labelled one to 
six (column 1). Concentration of CS as % w/v (column 2). CS added to solution in grams (column 3), 
and volume of 1% (v/v) AA in mL (column 4). 
Well Number CS (% w/v) CS (g) 1% (v/v) AA (mL) 
1 0.5 0.025 5 
2 1.0 0.050 5 
3 1.5 0.075 5 
4 2.0 0.100 5 
5 2.5 0.125 5 
6 3.0 0.150 5 
 
3.2.1.1.2 Lyophilization/Freeze-Drying Method 
Frozen CS solutions were freeze-dried in a FreeZone Triad Freeze Dry System 74000 
Series (Labconco, Missouri, USA) as follows. The temperature of the freeze dryer 
shelf was reduced to at least -40 °C before samples were placed inside with 
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subsequent activation of the vacuum. After 1 hour the temperature was increased to 0 
°C for the primary drying step. After 20 hours the temperature was increased to 20 °C 
to assist in the removal of residual water for secondary drying. 24 hours later the 
samples were collected. 3 mm and 8 mm biopsy punches (KRUUSE, Denmark) were 
used to create scaffolds that were used for analysis. 
 
3.2.1.1.3 Scanning Electron Microscope 
Preparation for Scanning Electron Microscopy (SEM) involved a scaffold that was cut 
transversely with a scalpel to reveal the interior. Both pieces were mounted on an 
aluminium stub using carbon tape as an adhesive. Samples were coated with 
approximately 15 nm of platinum palladium using an Emitech K575X Peltier-cooled 
high resolution sputter coater (EM Technologies Ltd, Kent, England) and viewed by a 
JEOL JSM-6700F Field Emission Scanning Electron Microscope (JEOL Ltd, Tokyo, 
Japan) at 5.0 kV and a LEI detector to acquire x25 and x100 images. 
 
3.2.1.1.4 Micro-Computed Tomography 
3 mm scaffolds were mounted on a sample holder of a Sky Scan 1172 high-resolution 
µCT scanner (Bruker, Kontich, Belgium). The scaffold was positioned so that 
radiation passed perpendicular to the samples largest width. Using micro-computed 
tomography software (Bruker), voltage was set to 30 kV and current to 175 µA. 
Camera settings were set to medium camera pixel. Approximately 1000 images of the 
scaffold in the form of transverse slices were taken. 
 
3.2.1.2 Secondary Chitosan Scaffold Manufacture 
3.2.1.2.1 Freezing Studies 
To determine if freezing temperature and duration affected the scaffold architecture, 5 
mL of 1% CS (w/v) solution was each placed in six 5 cm diameter petri dishes (BD 
Biosciences, Belgium) and left undisturbed overnight. 3 dishes were frozen at -80 °C 
for 24, 48 and 72 hours. The other 3 dishes were frozen at -22 °C for 24, 48 and 72 
hours. Samples were then freeze-dried as described in 3.2.1.1.2. An 8 mm biopsy 
punch was used to create scaffolds samples for analysis. 
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3.2.1.2.2 Container Studies 
Scaffolds were produced in containers of varying geometries to determine if this was 
a determinant of scaffold architecture. 1% (w/v) CS solution was used for the 
following experiments. Using 2 transfer pipettes (Biologix, USA) with an 8 mm 
diameter, 3 mL of solution was drawn up and the openings of the pipettes were then 
sealed with parafilm. Two 5 cm diameter petri dishes were filled with solution and 
sealed with a lid. Two 15 mL Falcon Tubes (Corning Life Sciences, USA) were filled 
completely with solution. One pipette, petri dish and Falcon tube was frozen at -22 °C 
and the other ones were frozen at -80 °C for 24 hours before being freeze dried 
according to 3.2.1.1.2. 3 mm scaffolds were punch biopsied for analysis. 
 
3.2.1.2.3 Secondary Scaffold Scanning Electron Microscopy 
Scaffolds were cut in half using a scalpel to produce two semi-circles in order to 
expose the interior surface and were mounted so that the interior was facing upwards. 
The other half was placed so that its most superior surface faced upward. Analysis 
was performed as according to 3.2.1.1.3. 
 
3.2.1.3 Macroconcentrations of Chitosan Scaffolds 
To improve the integrity of scaffolds, higher concentrations of CS were investigated. 
Macroconcentrations simply refers to larger concentrations of CS powder than 
previously used in 3.2.1.1.1. CS powder was added to 1% (v/v) AA to produce 
concentrations of 1.5, 2.0, 4.0, 8.0, 10.0 and 12.0% (w/v) as according to Table 3.2. 
The solutions that were highly viscous were manually mixed using a 1000 µL pipette 
tip to ensure the CS was dissolved. Samples were frozen at -22 °C (and from 
onwards, all scaffolds are frozen at this temperature) and freeze-dried as previously 
stated in 3.2.1.1.2.  
 
 
Table 3.2: Macroconcentrations of Chitosan Scaffold Protocol. Well number of 6 well culture dish 
labelled one to six (column 1). Concentration of CS as % w/v (column 2), CS added to each well in 
grams (column 3). Amount of 1% AA (v/v) added in mL (column 4). 
 30 
Well Number CS (% w/v) CS (g) 1%AA (v/v) (mL) 
1 1.5 0.075 5 
2 2.0 0.100 5 
3 4.0 0.200 5 
4 8.0 0.400 5 
5 10.0 0.500 5 
6 12.0 0.600 5 
 
 
3.2.1.4 Chitosan and Hydroxyapatite Scaffold Manufacture 
3.2.1.4.1  Chitosan and Micro-Hydroxyapatite Scaffold Manufacture 
To investigate the bioactivity and integrity of scaffolds, micro-hydroxyapatite (µHA) 
was added to 12 wells of 5 mL of 1% (w/v) CS solution as according to Table 3.3 
(low concentrations) and 3.4 (macroconcentrations, defined simply as larger 
concentrations than used in Table 3.3) below. Dish was placed on a plate shaker for 1 













Table 3.3: Chitosan Scaffold with Micro-Hydroxyapatite Protocol. Well number of 6 well culture 
dish labelled one to six (column 1). The volume of 1% (w/v) CS solution added in mL (column 2). 
µHA concentration showed as a % w/v (column 3), and µHA added in grams (column 4). 
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Well Number 1% (w/v) CS (mL) µHA (% w/v) µHA (g) 
1 5.0 0.00 0 
2 5.0 0.06 0.003 
3 5.0 0.10 0.005 
4 5.0 0.20 0.01 
5 5.0 0.40 0.02 




Table 3.4: Chitosan Scaffold with Macroconcentrations of Micro-Hydroxyapatite. Well number of 
6 well culture labelled one to six (column 1). Volume of 1% (w/v) CS added in mL (column 2). 
Concentrations of µHA shown as a % w/v (column 3). Amount of HA added in grams (column 4).  
Well Number 1% (w/v) CS (mL) µHA (% w/v) HA (g) 
1 5.0 1.0 0.05 
2 5.0 2.0 0.10 
3 5.0 4.0 0.20 
4 5.0 10.0 0.50 
5 5.0 15.0 0.75 
6 5.0 20.0 1.00 
 
 
3.2.1.4.2 Chitosan and Nano-hydroxyapatite Scaffold Manufacture 
It was investigated if nano-hydroxyapatite (nHA) was superior than µHA with regards 
to a greater amount incorporated into the scaffold for bioactivity and structural 
integrity. 5mL of 1% (w/v) CS solution was placed into each well of a 6 well cell 
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culture plate. nHA was added to each well as according to Table 3.5. The dish was 
placed on a plate shaker for 1 hour or until contents were dissolved. Samples were 
frozen at -22 °C for at least 24 hours before being freeze dried as previously stated in 
3.2.1.1.1 and underwent SEM analysis as in 3.2.1.1.2. 
 
Table 3.5: Chitosan and Nano-Hydroxyapatite Scaffold Protocol. Well number of 6 well culture 
dish labelled one to six (column 1). Volume of 1% CS (w/v)  solution in mL (column 2). Concentration 
showed as a percentage of the solution after subsequent nHA addition (column 3). Amount of nHA in 
grams added to the solution (column 4). 
Well Number 1% (w/v) CS (mL) nHA (% w/v) nHA (g) 
1 5.0 2.5 0.125 
2 5.0 3.0 0.150 
3 5.0 3.5 0.175 
4 5.0 4.0 0.200 
5 5.0 4.5 0.225 




3.2.1.4.3 8% (w/v) Chitosan scaffolds with Macroconcentrations of nHA 
8% CS (w/v) was chosen as the concentration as pores were well above 100 µm. 
therefore nHA could be added without having a significant effect on pore diameter. 
Macroconcentration simply refers to using larger amounts of nHA than used prior in 
3.2.1.4.2. 2.4 g of CS powder was added to 30 mL of 1% (v/v) AA to produce an 8% 
(w/v) solution of CS. 5 mL of this solution was placed into each well of a 6 well dish. 
nHA was added to each well as according to Table 3.6. The solutions were highly 
viscous and therefore were manually mixed using a 1000 µL pipette tip to make sure 
the powders dissolved. Samples were frozen at -22 °C and freeze-dried as previously 
stated in 3.2.1.1.1.  
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Table 3.6: Chitosan Scaffold with Macroconcentrations of Nano-Hydroxyapatite Protocol. Well 
number of 6 well culture dish labelled one to six (column 1), volume of 8% CS (w/v) solution in mL 
(column 2), concentration of nHA shown in % w/v (column 3), amount of nHA added to each well in 
grams (column 4). 
Well Number 8% (w/v) CS (mL) nHA (% w/v) nHA (g) 
1 5.0 2.5 0.125 
2 5.0 3.0 0.150 
3 5.0 3.5 0.175 
4 5.0 4.0 0.200 
5 5.0 4.5 0.225 
6 5.0 5.0 0.250 
 
 
3.2.1.5 Scaffold Characterization 
3.2.1.5.1 Scanning Electron Microscopy 
SEM images were taken as in 3.2.1.1.3 of 3 areas from the central region of an 8% 
(w/v) CS and 5% (w/v) nHA scaffold. ImageJ software (National Institutes of Health, 
Maryland, USA) was used to determine the average pore diameters. For improved 
visualization of pores, images were first converted to black and white using the 
threshold function to convert pore walls black and pores white. The next function was 
to filter the image to minimize background noise, removing specks and objects. The 
scale was set to convert pixels to µm. From each sample, 30 pores were measured. 
Data was plotted on Prism 6 (GraphPad Software) to generate a graph and statistical 
results. 
 
3.2.1.5.2 Micro-Computed Tomography of Scaffolds  
CT images were taken as done previously in 3.2.1.1.4. Using Skyscan Software 
‘CTan’ (Bruker), open and closed porosity was determined as a percentage using the 
method, ‘Advanced Porosity Analysis’ (Bruker microCT). 
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3.2.1.5.3 Scaffold Stabilisation and Rehydration Testing 
From here onwards, scaffolds used for experimentation are 8% w/w CS and 5% nHA, 
as prepared in 3.2.1.4.3. When ‘scaffold’ is mentioned it will refer to the 
aforementioned material concentrations. 
 
Freeze-dried scaffolds are precipitated polymers of chitosan acetate. If placed in 
aqueous conditions i.e. water, acetic acid would liberate hydrogen ions and hence re-
dissolve the chitosan. Using a solvent (absolute ethanol) allows the removal to acetic 
acid without liberating hydrogen ions and hence stabilises the scaffold. 8 mm 
scaffolds were immersed in absolute ethanol for 1 hour and followed by immersion in 
90, 80, 70 and 50% ethanol solutions for 30 minutes each. This was followed by 
immersion in distilled water for 30 minutes. Scaffolds were then placed into culture 
dishes with distilled water, frozen and freeze-dried again as in 3.2.1.1.1. SEM 
analysis was performed as in 3.2.1.1.2. Scaffolds that have been treated with alcohol 
will be referred to as ‘stabilised’. 
 
3.2.1.5.4 Scaffold Degradation and pH 
This method was used to determine if scaffolds degraded and affected the local pH in 
vitro. This was achieved by placing the scaffold in simulated physiological conditions 
to determine structural integrity over time, as the scaffold needs to remain stable to 
support the local environment for bone regeneration. Ideally, the degradation rate 
should match bone regeneration. To ensure a precise measurement of dry weight was 
made, the scaffolds were freeze-dried before and after degradation step. Scaffolds 
were weighed a 9 stabilized and freeze-dried scaffolds weighted and placed into 
individual wells of a 12 well culture plate. 2 mL of PBS was placed into each well. 
The plate was placed into an incubator at 37°C and 5% CO2. At time 24, 48 and 168 
hours, 3 scaffolds were removed, immersed in distilled water and frozen. An Orion 
230A pH meter (Thermo Fisher Scientific, Auckland, New Zealand) measured the pH 
of each well at each of the time points when scaffolds were removed. When all 
scaffolds are frozen they all underwent freeze-drying as previously stated in 3.2.1.1.1. 
Scaffolds were weighed once again and data analyzed. The sensitivity of the weighing 
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instrument was to 3 decimal points. The measurement taken was when there was no 
fluctuance of the scale display, that is, when the reading was constant. 
 
3.2.1.5.5 Scaffold Swelling Tests  
To investigate the response of scaffolds in aqueous solution, 3 stabilized and freeze-
dried scaffolds were placed in separate wells of a 6 well plate and immersed in 5 mL 
of PBS.  Using forceps, scaffolds were immediately weighed (time = zero) after PBS 
immersion by placement onto a paper towel on a scale 6 times, ensuring the scale is 
zeroed before each measure. The scaffolds were placed in a 37°C, 5% CO2 incubator. 
Scaffolds were weighed at 1, 3 and 7 days post immersion in PBS in the same manner 
as previously done at time = zero.  
 
3.2.1.5.6 Scaffold Sterilisation 
Two methods were attempted for scaffold sterilization. A freeze-dried and stabilised 
scaffold was placed into an autoclave at 121 °C for 20 minutes after 15 PPI was 
reached. Once autoclaved the scaffold underwent gross observation and SEM analysis 
as in 3.2.1.1.3. 
 
The following protocol involves sterile conditions in a laminar flow hood. Stabilized 
and freeze-dried scaffolds were placed in 15 mL Falcon tubes with 10 mL of absolute 
ethanol. These are left to rest for at least 24 hours. The ethanol is removed and the 
scaffolds were transferred to a 15 mL Falcon tube with 10 mL of sterile distilled 
water. After 24 hours the scaffolds were removed and placed in a 6 well plate and 
immersed with 5 mL of growth media.  All subsequent methods and protocols 
involved in using the scaffold were done under sterile conditions. 
 
3.2.1.5.7 Fourier Transform Infrared Spectroscopy 
FTIR was employed to collect infrared spectra to describe molecular vibrations. An 
8% (w/v) CS and 5% (w/v) nHA scaffold was crushed into a fine powder using a 
mortar and pestle. 0.01 g of this powder was mixed with 0.1 g of potassium bromide 
(KBr) and further mixed using a mortar and pestle. The resulting mixture was pressed 
into discs and analyzed using a Spectrum RX1 (Perkin Elmer Instruments, USA) with 
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a 4 cm-1 resolution. Spectra were collected over the range of 400 – 4000 cm-1; with 
the background noise corrected by KBr. 16 scans were taken to give an average 
spectra.  
 
Energy Dispersive X-Ray Spectroscopy 
EDS was employed to determine the elemental composition of the scaffold. An 8% 
(w/v) CS and 5% (w/v) nHA scaffold was analyzed using a JEOL-2300 Energy 
Dispersive Analyzer and JEOL AnalysisStation software (JEOL, Germany). 
Accelerating voltage used a negative potential of 15 kV, and the sample was analyzed 
using ‘spot analysis’ for 2 minutes to collect elemental peaks. 
 
3.2.2 Cell Culture Investigations with Osteogenic Sarcoma Cell Line and 
Mesenchymal Stem Cells 
 
3.2.2.1 Growth Media Production 
Under sterile conditions, a 500 mL bottle of ready to use Dulbecco’s Modified 
Eagle Media (DMEM) or Alpha-Minimum Essential Media (α -MEM) culture 
medium had 55 mL of media removed. 50 mL of heat inactivated FBS and 5 mL of 
Anti-Anti (10,000 units/10 mL penicillin, 10 µg/10 mL streptomycin, 25 µg/mL 
amphotericin B) were added to the media bottle. 40 mL aliquots were placed in 50 
mL Falcon tubes (to prevent freezing-mediated bursting) and frozen at -22 °C for 
storage.  This media solution of DMEM or α-MEM with 10% FBS and 1% Anti-
Anti solution is referred to as growth media. Growth media using powder was made 
according to manufacturer’s instructions. A 1 L solution had 110 mL of media 
removed and 100 mL of FBS and 10 mL of Anti-Anti was added. The resultant 
solution was filter sterilized with a syringe (TERUMO®) and a 0.2 µm syringe filter 
(AVS Filter Technologies). This solution of DMEM or α-MEM with 10% FBS and 
1% antibiotic/antimicotic solution is referred to as growth media. 
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3.2.2.2 SAOS-2 Cell Line Culture 
3.2.2.2.1 SAOS-2 Cell Thawing 
For SAOS-2 (American Type Culture Collection; Virginia, USA) cell culture, growth 
media will refer to α-MEM. Cryovials (Corning Life Sciences; USA) containing the 
frozen cell line were thawed rapidly in a 37 °C water bath. Under sterile conditions in 
a laminar flow hood the contents of the cryovial are added to a 15 mL Falcon tube 
containing 10 mL of growth media. The Falcon tube was then centrifuged for 3 
minutes at 120 g. The supernatant was discarded and the cell pellet was resuspended 
in 1 mL of growth media. Cells were then plated in a 25 cm2 cell culture flask and left 
in a 37 °C, 5% CO2 incubator. 
 
3.2.2.2.2 SAOS-2 Cell Culture and Passage 
After the thawing process the cells were allowed to reach 70-80 % confluence, which 
was observed by phase contrast microscopy. Once the desired confluency was 
reached the cells were passaged as follows. Under sterile conditions in a laminar flow 
hood the growth media was removed from the cell flasks and washed twice with 
Dulbecco’s phosphate buffered saline (DPBS) to remove debris and unattached cells. 
2 mL of trypsin/EDTA was added to remove adherent cells on the culture surface. 
The culture flask was placed in the incubator to optimize trypsin activity. After 5 
minutes the flasks were tapped on a bench to assist the dissociation of cells. Using a 
phase-contrast microscope confirmed non-adherent cells in solution. In the hood, 6 
mL of growth media was added to the flasks to neutralize the trypsin. The contents of 
the flask were added to a 15 mL Falcon tube that was centrifuged for 3 minutes at 
120g. The supernatant was removed and the cell pellet was resuspended in 2 mL of 
growth media. 6 mL of growth media was added to two 25cm2 cell culture flasks. The 
resuspended cells were added to the flasks drop wise. The amount was dependent on 
the desired rate of reaching 70-80% confluency. The flasks were then placed into the 




3.2.2.2.3 SAOS-2 Cryopreservation 
A 20% dimethyl sulphoxide (DMSO) (EMD Chemicals, Pennsylvania) solution was 
made with growth media under sterile conditions and kept on ice. Cells were lifted 
using trypsin, centrifuged and resuspended in 2 mL of growth media. Cells were 
counted using a Countess Automated Cell Counter (Invitrogen). Cell suspensions 
were diluted to a cell density of 1x106 cells/mL or centrifuged, resuspended to a cell 
density of approximately 1x106 cells/mL. 500 µL of these cell suspensions were 
placed into a 1.2 mL cryovial and 500 µL of the prepared DMSO solution was added 
drop wise. Cryovials were sealed and placed in a Nalgene® cryofreezing container 
(Thermo Scientific, USA) with isopropanol to control freezing rates before being 
placed in an -80 °C freezer. After 3 days the cryovials are removed and stored as 
required at -80 °C for up to 6 months.  Long-term storage greater than 6 months was 
done in liquid nitrogen. 
 
3.2.2.2.4 SAOS-2 Cell Seeding  
Three sterilized CS scaffolds were immersed in α -MEM media for 24 hours. 
Scaffolds were then removed from the media and individually placed into the wells of 
a 6 well plate. 3 glass coverslips were placed in other wells and acted as a control. 
Following cell passaging, 6000 cells were seeded onto each scaffold and coverslip in 
100 µL of media, and placed in an incubator at 37 °C and 5% CO2 for 60 minutes to 
allow cells to adhere, 5 mL of media was then added into each well. Cells were 
maintained for 24, 48 and 96 hours then underwent a LIVE/DEAD≠ assay. 
 
3.2.2.2.5 LIVE/DEAD® Cell Viability/Cytotoxicity Assay 
The numbers of live and dead cells were assessed using the aforementioned assay as 
follows. Under sterile conditions, media was removed from each of the wells and 
replaced with 5 mL of DPBS warmed to 37 °C. This is subsequently removed and 100 
µL of assay solution (4 µM calcein AM and 4 µM of ethidium homodimer-1 in 
DPBS) was pipetted onto each scaffold and incubated for 30 minutes. A glass 




Visualization of fluorescence was done with a confocal laser-scanning microscope 
(Zeiz LSM 510 Confocal Microscope) and Zen 2009 software (Carl Zeiss 
MicroImaging GmbH, Jena, Germany). Living cells were identified due to 
metabolism of calcein AM to calcein (excitation 494 nm, emission 517 nm). Dead 
cells were identified due to incorporation of ethidium homodimer-1 into the nucleus 
as cell membranes were damaged (excitation 528 nm, emission 617 nm). Cell counts 
were performed in 3 randomly chosen fields per scaffold at x4 and x10 magnification. 
Viability of cells in each image was calculated as follows: 
 
𝐶𝑒𝑙𝑙 𝑉𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦 (%) =
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝐿𝑖𝑣𝑒 𝐶𝑒𝑙𝑙𝑠
𝑇𝑜𝑡𝑎𝑙 𝐶𝑒𝑙𝑙 𝑁𝑢𝑚𝑏𝑒𝑟
 𝑥 100 
 
Average viability was calculated and presented with the average total cell number. 
This was to provide a comprehensive view of the cellular response to the scaffold 
material and prevents the misrepresentation of the scaffold as cytocompatible (for 
example, if 90% of the cells were viable but only 10 cells were present this would 
represent cytotoxicity). A one-way ANOVA with Bonferroni’s post hoc analysis was 
used to compare cell viability and total cell number for all of the scaffolds. 
3.2.2.2.6 CellTiter 96® AQueous One Solution Cell Proliferation Assay  
Also known as the MTS assay, this demonstrated that the scaffold is not cytotoxic and 
therefore allowed cells to proliferate. An 8% (w/v) CS and 5% (w/v) nHA scaffold, 
collagen scaffold and Triton-X were chosen for this assay. A modified International 
Organization for Standardization (ISO) to test for in vitro cytotoxicity was performed. 
The modification involved a larger weight of scaffold as done prior by Stace 2011. A 
2 mg sterile CS/nHA scaffold was immersed in 2 mL of growth media, a sterile 2 mg 
collagen scaffold was immersed in 2 mL of growth media, and 2 mL of a 0.1% 
Triton-X solution was made with growth media. All 3 were placed in an incubator for 
48 hours. These 3 solutions were known as extraction vehicles (elusion fluid) that 
could have taken up potentially cytotoxic elements from each scaffold and therefore 
affected proliferation of cells. Collagen was known not to be cytotoxic and was the 
negative control as there was no cytotoxic response, whereas Triton-X, a detergent, 
will kill all cells and therefore acted as the positive control, as there was a cytotoxic 
response. The CS/nHA scaffold was the experimental (test) vehicle. 
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3000 SAOS-2 cells were seeded onto 9 wells of a 96 well plate, 100 µL of chitosan, 
collagen and Triton-X vehicle were added to 3 wells each. Another 3 wells were 
pipetted with 100 µL of growth media made up the blanks. Cells were incubated for 
0, 24, 48 and 72 hours. Time 0 hour cells immediately went through the MTS assay 
once seeded.  
 
The MTS assay was done according to manufacturer’s instructions. 20 µL of MTS 
solution was added to each well and left to incubate for 2.5 hours. The absorbance 
value was read using a Synergy 2 Multi-Mode Microplate Reader (Biotek®) at 490 nm 
and data was recorded using Gen5 1.11 software. The software automatically 
produced data and provided means, standard error and coefficient variance. Data was 
graphed using Prism 6 (GraphPad Software). 
 
3.2.3 Three Dimensional Perfusion Circuit 
3.2.3.1 Perfusion Circuit Components 
This project involved the use of a 3D perfusion circuit that was designed, fabricated 
and utilized by Stace 2011. It consists of a custom designed bioreactor, media 
reservoir, peristaltic pump and tubing. Images of components and assembled 
bioreactor are found below in Figure 3.1, with a conceptual diagram of the entire 
circuit shown in Figure 3.2. 
 
The Major Scientific MFU-02 pump (Major Science, USA) consisted of 4 separate 
heads with surrounding rollers that rotate to compress the tubing in order to create 
peristaltic flow. The pump allowed control over flow rate and flow direction could be 
reversed if required. Flow rates were manually calculated, as rates provided by the 
manufacturer were erroneous. Flow rates were calculated by running the circuit for 1 
minute, and measuring the volume of fluid that was pumped into a 50 mL Falcon 
Tube. 
 
The silicon tubing used was Tygon 3350 as it was permeable for gas exchange, non-
toxic and had a low protein affinity. Another type of tubing, Tygon Pharmed BPT was 
used to replace the Tygon 3350 that was compressed by the rollers of the pump. 
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Although Tygon Pharmed BPT had a low ability for gas exchange, it was durable and 
was resilient to damage by the roller heads. 
 
The bioreactor was fabricated by Electromechanical Technology for Teaching and 
Research (EMTECH), University of Otago. It comprised of a chamber to house the 
scaffold and designed to allow laminar flow only. The growth chamber that housed 
the scaffold is 8 mm in diameter to house scaffolds of 8 mm for rodent critical size 
defects. The growth chamber was surrounded on both sides by a metal mesh with 
notches to allow air bubbles to accumulate and avoid the scaffold. The components of 
the bioreactor allowed an easy fit and seal from the outside environment.  
 
The media reservoir was a modified Schott bottle with side arms topped with 0.22 
micron filter membrane to allow gas exchange. The bottle had a modified lid with two 
entry points made of stainless steel tubes. One allowed for media to return drop wise 
into the reservoir, and the other draws media out into the circuit. All components of 





























Figure 3.1: Perfusion Circuit Components. (A) bioreactor components, left to right: outer chamber, 
inner chamber, titanium core, inner chamber, outer chamber, (B) mesh that surrounds scaffold chamber 
with arrow pointing to notch to allow air bubbles to escape, (C) assembled bioreactor, (D) media 
reservoir side arm components, from left to right: cap for bottom side arm, plastic washer, rubber seals, 
0.22 µm membrane filter, cap (E) media reservoir top cap components, steel tubes within (from left to 
right) rubber seal, cap insert and cap, (F) assembled media reservoir, (G) Tygon (top) and PharMed 




Figure 3.2: Conceptual Diagram of Perfusion Circuit for 3D Culture. (A) media reservoir, (B) 
Tygon tubing, (C) PharMed BPT tubing, (D) peristaltic pump, (E) Tygon tubing, (F) bioreactor, (G) 
incubator, (H) entry/exit point for tubing through incubator. Arrows indicates direction of media flow. 
 
3.2.3.2 Three-Dimensional Culture of Osteogenic Cell Line 
6000 SAOS-2 cells in 20 µL growth media were seeded onto a sterile scaffold and left 
in an incubator for 1 hour, then 5 mL of growth media was added and left for a further 
24 hours and allowed cells to attach. All components were sterilized by autoclave, 
except the bioreactor, which was sterilized for 24 hours in UV light on each side of 




45 mL of growth media (warmed to 37 °C) was added to the media reservoir and side 
arms were sealed. PharMed and Tygon tubing was then assembled to the circuit 
according to Figure 3.2, but omitted connection of the tubes to the bioreactor. Using 
sterile forceps, the scaffold was carefully placed into the titanium core and sealed by 
the inner and outer chambers to form the bioreactor. The tubing was connected to the 
bioreactor. It was ensured the seeded surface of the scaffold faced the incoming 
direction of media flow.  
 
The perfusion system was then placed in the incubator and tubing was pushed through 
the outlet. The tubing was placed on a roller head of the pump. The pump was 
activated initially at 0.1 mL/min. Before media reached the bioreactor, the speed was 
reduced to 0.03 mL/min (lowest setting). The bioreactor was adjusted so that the 
notches in the metal meshes faced upwards and manually angled to allow air to 
escape through the notches. Once air bubbles were pumped out, the bioreactor was 
placed with notches facing upwards. The speed was then increased to 0.3 mL/min. In 
24 hours, the speed was increased to 0.6 mL/min and in another 24 hours the speed 
was increased to 1 mL/min. The scaffold was incubated for a total of 14 days. At 7 
days, the 45 mL of growth media was replaced and pH measured. pH was also 
measured at the completion of the experiment at 14 days. 
 
6000 SAOS-2 cells in 20 µL were seeded onto 24 UV sterilized coverslips placed into 
wells of a 24 well plate. 1 mL of growth media was added to each well and the plate 
was placed in an incubator. Media was replaced every 3 days. These coverslips acted 
as the control experiment. 
 
3.2.3.3 Scaffold and Coverslip Fixation 
After 14 days the scaffold was removed from the bioreactor and immersed into 10 mL 
of 4% (v/v) paraformaldehyde solution. The scaffold remained in solution for at least 
6 hours before being embedded in paraffin wax. The wax block is then cut 
longitudinally using a microtome to acquire 5 µm sections of scaffold and placed on 
slides. Decalcification prior to sectioning was required due to damaged samples. The 
slides were stained as follows in 3.2.3.4. An uncultured 8% (w/v) CS scaffold with no 
added nHA followed the scaffold preservation protocol as above. As there was no 
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nHA and did not go through cell culture it cannot be stained for mineralization or 
cells.  
 
Glass coverslips seeded with SAOS-2 cells were fixed as follows. Media was 
removed from the wells of a 12 well plate and replaced with enough 4% 
paraformaldehyde to cover the glass slips. After 20 minutes of fixation in an 
incubator, the paraformaldehyde was removed and replaced with 70% ethanol to 
completely fill the well (prevent losses due to evaporation). The plate was then placed 
in a fridge (4 °C) until required for histological staining as in 3.2.3.4. 
 
3.2.3.4 Histology Protocols 
All staining was performed in the University of Otago Histology Unit. All materials 
were provided and protocols were provided and are as follows. Most staining 
solutions were aqueous and wax is immiscible with water. This wax must be 
dissolved with xylene and ethanol series and is described as follows. Slides were 
placed in xylene baths for 2 minutes each, 3 times. This was followed by 2 baths of 
absolute ethanol for 2 minutes each, 95% alcohol for 2 minutes, and 70% alcohol for 
2 minutes and finally left in tap water prior to processing. 
 
3.2.3.4.1 Haemotoxylin and Eosin (H&E) 
Deparaffinised slides or coverslips were stained with Gill’s Haematoxylin for 4 
minutes and rinsed well in running water baths. A slide was then dipped in acid 
alcohol for 4 seconds for differentiation, and washed in running water until sections 
turned ‘blue’. If the blue change did not occur, the acid alcohol and washing steps 
were repeated. Dehydration of slides followed using 70%, 95% and absolute alcohol. 
The slides were then stained with 0.5% alcoholic eosin Y for 1 minute. Dehydration 
followed once again using 70%, 90% and absolute alcohol. Slides were then cleared 
in xylene (1 minute, 4 times) and mounted using DPX (distrene 80, dibutyl phthalate, 
xylene, butylated hydroxytoluene) or Entellan mounting media. Imaging was 
performed using an Olympus AX70 Light Microscope. 
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3.2.3.4.1.1 Fluorescent Microscopy of Haematoxylin and Eosin Stained Scaffolds 
Using an Olympus AX70 Light Microscope slides were visualized with fluorescent 
settings. The H&E slide was imaged at x20 magnification, using 496 nm excitation 
and 519 nm emission wavelength. Bandpass filter was 460 – 490 nm. This resulted in 
a ‘green’ emittance. 
3.2.3.4.2 Van Gieson 
Dewaxed slides or coverslips in water were stained with Gill’s Haematoxylin no. 2 
for 4 minutes, rinsed, and ‘blued’ in Scott’s Tap Water for 1 minute. Sections were 
rinsed in running water and then stained with Van Gieson for 4 minutes. Sections 
were then dehydrated, cleared with xylene and mounted, and imaged as previously 
mentioned in 3.2.3.4.1. 
 
3.2.3.4.3 Mason’s Trichrome 
Dewaxed slides or coverslips in water were stained with Weigert’s Haematoxylin for 
10 minutes and washed in tap water. This was followed by staining in acid fuchsin 
solution for 5 minutes and rinsed in distilled water. The sections were treated with 1% 
phosphomolybdic acid for 5 minutes and rinsed briefly. They were then stained with 
methyl blue solution for 2-5 minutes and rinsed again before treating with 1% acetic 
acid. Slides/coverslips were dehydrated with alcohol, cleared with xylene, mounted 
and imaged as previously mentioned in 3.2.3.4.1. 
 
3.2.3.4.4 Alizarin Red 
A 2% Alizarin Red solution was made up with 10 mL of distilled water and 0.2 g of 
Alizarin Red powder. The pH was adjusted to 4.2 using sodium hydroxide and 
hydrochloric acid. Dewaxed coverslips/slides in water were air dried and then stained 
with alizarin red for 5 minutes. Coverslips were then dipped in distilled water to 
remove excess stain. Slides/coverslips were dehydrated with alcohol, cleared with 
xylene, mounted and imaged as previously mentioned in 3.2.3.4.1. 
 
3.2.3.4.5 Von Kossa 
Dewaxed coverslip or slides, plus a human prostate control section were immersed in 
tap water. The prostate control section is known to have calcium deposits and will 
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show obvious black staining with Von Kossa. Sections were washed in distilled water 
and covered with 5% silver nitrate. The sections were either placed under a 60 watt 
bulb (4-5 inches away) for 30-60 minutes or UV light for 10-20 minutes. Following 
washing in several changes of distilled water, slides are treated with 5% thiosulfate 
for 2-3 minutes. Slides are then counter-stained with Van Gieson and dehydrated, 
cleared, mounted and imaged as in 3.2.3.4.1. 
 
3.2.4 Bone Marrow Cell Retrieval 
3.2.4.1 Animal Ethics 
The Hercus Taeiri Resource Unit (University of Otago) was covered by their Animal 
Ethics Committee protocols for culls.  
 
3.2.4.2 Rat Euthanasia 
A male, adult Wistar rat was euthanized according to the University of Otago Animal 
Welfare Office CO2 protocol. The rat was placed in a plastic chamber connected to a 
CO2 source. CO2 was let into the chamber until it was observed that the rat was still 
and not breathing. Confirmation of necropsy was by palpating for a pulse, observing 
respiration and testing for the pedal reflex. 
 
3.2.4.3 Rat Femur Retrieval 
The following was a modified protocol by Stace 2011. On autoclaved drapes, the rat 
was shaved around the thighs and lower back. Another set of drapes was sprayed with 
chlorhexidine gluconate (hibitane) disinfectant before the placement of the rat dorsal 
side up. The hip joint was first dislocated. This was done by placing pressure on the 
pelvis and lifting the femur superiorly until dislocation was felt. Using a number 22 
scalpel on a number 4 scalpel handle, incisions were made from the lateral aspect of 
both knee joints to the vertebral column. Further incisions were made through the 
musculature of the leg until the femur was reached. Surgical retractors pulled the skin 
and muscle back for observation. Incisions were made to separate the surrounding 
muscles from the femur. The muscle tendons were removed from the femur using 
additional incisions made proximally and distally to reach the hip and knee joints 
respectively. A scalpel was used to cut at both joint capsules until the femur was free. 
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Any additional muscle and connective tissue was removed before placing the femurs 
into a 50 mL Falcon tube with 40 mL of hibitane. 
3.2.4.4 Bone Marrow Retrieval 
This protocol followed that by Stace 2011. In sterile conditions in a laminar flow 
hood, the femora were placed on paper towels. Using a number 22 scalpel blade and a 
number 4 scalpel handle, the femora were cut midway to expose the medullary cavity. 
10 mL of DMEM was drawn into a syringe fitted with a 20 gauge needle and inserted 
into the medullary cavity, where growth media was flushed inside to expel the bone 
marrow. The contents were collected below in a plastic 94 mm dish. The contents of 
the dish were filtered through a 100 µm cell strainer on top of a 50 mL Falcon tube. 
10 mL of media (containing marrow components) was plated into four 25 cm3 culture 
dish and placed into an incubator at 37 °C and 5% CO2. Each femur’s contents were 
collected into separate plastic dishes. 
 
3.2.5 Bone Marrow Cell Culture  
This protocol also followed that by Stace 2011. After 24 hours for cell attachment, 
isolation of cells began. In sterile conditions within a laminar flow hood, the culture 
plates were rinsed with 2 mL of DPBS, three times, to remove debris and unattached 
cells. 6 mL of growth media was placed into flasks. The plates were placed back into 
an incubator for 3 more days. After 3 days the cells were passaged as done previously 














4.1 Scaffold Manufacture 
 
4.1.1 Primary Scaffold Manufacture 
4.1.1.1 Gross Appearance 
Chitosan (CS) dissolved in acetic acid (AA) resulted in pale yellow solutions that 
increase in color intensity and viscosity with higher concentrations. Air bubbles get 
increasingly trapped with increasing viscosity. Freezing at -80 °C resulted in the 
appearance of central fractures with the periphery looking like cream-tinged ice. As 
depicted in Figure 4.1, freeze-drying results in approximately 1 cm high discs that 
have the presence of dull, yellow and glossy material with cracks (arrowhead), with 
the severity of cracks increasing as CS concentration increased. There are smaller 
cracks that originated from larger cracks. There were some peripheral regions 
(arrows) in the wells that were not fractured and were opaque, foamy and cream in 
color.  It appeared that the peripheral, foamy regions emerged in random locations of 
the 6 well plates as the chitosan concentration increased. The peripheral region 
resulted in inadequate amounts for production of 8 mm diameter scaffolds, especially 
with increased chitosan concentration for strength requirements. A biopsy punch was 
used to retrieve samples from the center of the well and it compressed rather than cut, 





Figure 4.1: Freeze-Dried Chitosan Scaffolds. Wells contain 5 mL of CS (w/v) solution that has been 
freeze-dried as stated previously. There are noticeable fractures (arrowhead) in the center of each 
scaffold with a white foamy periphery (arrow) of each well. CS concentrations: A) 0.5%, B) 1.0%, C) 
1.5%, D) 2.0%, E) 2.5%, F) 3.0%. 
Figure 4.1: Freeze-Dried 1% (w/v) Chitosan Scaffold. Wells contain 5 mL of 1% CS (w/v) solution that has been 
freeze-dried as stated previously. There are noticeable fractures (arrowhead) in the center of each scaffold with a white 
foamy periphery (arrow) of each well. 
4.1.1.2 Scanning Electron Microscopy  
Scanning electron micrographs (SEM) of a 3 mm scaffold from all samples retrieved 
from the central area showed a smooth surface on the most superior layer, with the 
interior showing a highly layered architecture of chitosan sheets. The smooth layer is 
shown in figure 4.2 (A). 4.2 (B) demonstrated the layers of chitosan under the top 
surface after the top layer is removed by scalpel. The layers became more extensive 
with increasing chitosan concentration and did not appear to be interconnected.  
 
 
A. B. C. 




Figure 4.2: Scanning Electron Microscopy Images of Freeze-Dried Chitosan Scaffolds Frozen at  
-22 °C. (A) Shows the transverse view of a 1% (w/v) CS scaffold showing the smooth surface (arrow) 
of the most superior layer. (B) Shows the transverse view of the interior of a scaffold made from 1% 
(w/v) CS, showing a layered architecture with no obvious orientation of layering. Images taken at x25 
magnification. 
 
4.1.1.3 Micro-Computed Tomography Analysis 
Micro-computed tomographs (µCT) of a 3 mm 1% (w/v) scaffold from the central 
area provided approximately 500 images. Figure 4.3 shows a highly layered 
architecture in all CS concentrations with an obvious pointed oval shape of the 
scaffold due to biopsy compression as mentioned previously. Further analyses of 




Figure 4.3: Micro-Computed Tomography Image of 1% (w/v) Chitosan Scaffold. A highly layered 
architecture is seen with layers becoming closer together at the sides due to compression by punch 
biopsy. Scale bar = 1.0 mm increments. 
 
 
4.1.2 Secondary Scaffold Manufacture 
 
4.1.2.1 Freezing Studies 
4.1.2.1.1 Gross Appearance 
Scaffolds produced by freezing in -22 °C were similar in appearance to the peripheral 
region of the primary scaffolds, with the entirety looking like cream, translucent ice. 
The scaffolds that were frozen at -80 °C showed the characteristic cracks as described 
before in 4.1.1.1 Freeze-drying resulted in the -22 °C samples looking opaque, cream 
in color and having a foam-like consistency as depicted in Figure 4.4 (A). There was 
increased roughness of the surface with increasing freeze times. The -80 °C samples 
had cracks that increased in intensity with increased freezing time as shown in Figure 




Figure 4.4: Freeze-Dried Chitosan Scaffolds Frozen at Various Temperatures and Durations. (A) 
Shows three 1% (w/v) chitosan scaffolds frozen at -22 °C and (B) shows three 1% (w/v) chitosan 
scaffolds frozen at -80 °C. Scaffolds are frozen for 24, 48, and 72 hours and are displayed from left to 
right. 
 
4.1.2.1.2 Scanning Electron Microscopy Analysis 
SEM analysis of the scaffolds frozen at -22 °C showed a highly porous structure in all 
scaffolds as shown in Figure 4.5 (A). The transverse samples showed some distortion 
of the pore walls due to mechanical handling by forceps and cutting with a scalpel so 
that it does not give a clear outline of the pore. The -80 °C samples depicted in Figure 
4.5 (B) show the characteristic layered architecture as previously described.  With 
increasing freezing time there seemed to be a change in pore size. Porous structures 













Figure 4.5: Scanning Electron Microscopy Images of Chitosan Scaffolds Frozen at Various 
Temperatures and Durations. (A) three 1% (w/v) chitosan scaffolds frozen at -22 °C, sectioned to 
show a longitudinal view. (B) three 1% (w/v) chitosan scaffolds frozen at -80 °C and sectioned to show 
a transverse view. (i) scaffolds frozen for 24 hours, (ii) scaffolds frozen for 48 hours, and (iii) scaffolds 









4.1.2.2 Container Studies 
Adequate visualization of the frozen samples were unable to be obtained due to the 
opaque container walls obscuring the view. The gross appearance of freeze-dried 
samples frozen at -22 °C looked opaque, cream and foam-like, whereas samples 
frozen at -80 °C looked cracked both as previously stated in 4.1.2.1.1. (A) and (B) 
demonstrate SEM images of scaffolds produced in 15 mL Falcon tubes, with (A) 
showing a porous structure after being frozen at -22 °C, and (B) showing a layered 
structure after being frozen at -80 °C. (C) and (D) shows SEM images of scaffolds 
produced in large petri dishes, where (C) shows a porous structure after being frozen 
at -22 °C, and (D) shows a layered structure after being frozen at -80 °C. There seems 
to be no obvious orientation of all the porous structures. The sample in a transfer 
pipette proved to be unsuccessful as freeze-drying caused the frozen scaffold material 
to expel from the container when the vacuum pump was turned on, causing it to melt 




























Figure 4.6: Scanning Electron Microscopy Images of 1% (w/v) Chitosan Scaffolds Prepared in 
Various Containers. (A) Shows a scaffold frozen at -22 °C in a 15 mL Falcon tube, (B) shows a 
scaffold frozen at -80 °C in a 15 mL Falcon tube, (C) shows a scaffold frozen at -22 °C in a petri dish, 
(D) shows a scaffold frozen at -80 °C in a petri dish.   (i) images are shown at x25 magnification, (ii) 
images are shown at x100 magnification. 
 
4.1.2.3 Macroconcentrations of Chitosan in Scaffolds 
4.1.2.3.1 Gross Appearance 
Addition of concentrations above 2% (w/v) CS to 1% (v/v) AA resulted in very 
viscous and pale yellow solutions, with no obvious difference between 
concentrations. The use of a 1000 µL pipette tip was sufficient to mix and break down 
clumps of chitosan without the introduction of significant amounts of air bubbles. 
Scaffolds from now onwards were prepared by freezing at -22 °C. These frozen 
scaffolds had translucent surfaces with an opaque, yellow-cream interior. Once 
freeze-dried the scaffolds looked cream colored, dense foam-like structures with a 
paler periphery.  The remains of air bubbles on an 8% CS (w/v) scaffold are shown in 
Figure 4.7 and are shown as the small circles on the top surface. Biopsy sampling was 














Figure 4.7: Freeze-Dried 8% (w/v) Chitosan Scaffold. 5 mL of 8% CS (w/v) was freeze-dried in a 
well of a 6 well plate. There is a space in the bottom left of the scaffold to demonstrate biopsy 
sampling. Noticeable specks in the CS due to air bubbles (arrow). 
 
4.1.2.3.2 Scanning Electron Microscopy Analysis 
As shown in Figure 4.8, SEM analysis revealed a porous architecture with a trend of 
decreasing pore size as chitosan concentration increased. There was an obvious 
increase in the homogeneity of the pores at 4% (C) and 8% (w/v) CS (D), with less 
rectangular pore shapes and more ovoid and circular in nature. Increasing 
concentrations beyond 10% resulted in scaffolds of insufficient pore size for cell 
























Figure 4.8: Scanning Electron Microscopy Images of Macroconcentrations of Chitosan Scaffolds. 
(A) 1.5%, (B) 2%, (C) 4%, (D) 8%, (E) 9%, (F) 10%, (G) 11% and (H) 12% (w/v) CS. Pores are 
measured as depicted by red text. Images are taken at x100 magnification.  
 
4.1.2.4 Chitosan and Micro-Hydroxyapatite Scaffolds 
4.1.2.4.1 Gross Appearance  
CS solutions of 1% (w/v) that were described previously in 4.1.2.1.1 became 
increasingly white and opaque with the addition of micro-hydroxyapatite (µHA). 
Higher concentrations saturated the solution and were suspended in solution with 
some particles resting on the surface of the culture well. The freeze-dried scaffolds 
were opaque and cream in color, with foam-like consistency as previously found.  
 
4.1.2.4.2 Scanning Electron Microscopy Analysis 
As shown in Figure 4.9, SEM analysis of the internal structure of the scaffolds 
showed a highly porous architecture. As µHA concentration increased there was an 
observable decrease in pore size. There was also an increase of the walls collapsing 
into the pore. These collapsing walls looked like frills, looked frail and obscured the 









Figure 4.9: Scanning Electron Microscopy Images of 1% (w/v) Chitosan Scaffolds with Various 
Micro-Hydroxyapatite Concentrations. (A) 0%. (B) 0.05%. (C) 0.1%. (D) 0.2%. (E) 0.4%. (F) 0.6 % 








4.1.2.5 Chitosan and Macroconcentrations of Micro-Hydroxyapatite 
4.1.2.5.1 Gross Appearance  
The CS solutions increased in opaqueness with increasing µHA with a large layer of 
µHA that settled on the bottom of the culture wells, especially at 4% (w/v) and above. 
The appearance of the freeze-dried scaffolds showed the cream, opaque color 
gradually become chalk like in appearance with increasing µHA concentration. There 
was also a large increase in scaffold friability, as biopsy sampling was a great 
difficulty.  The µHA samples at 4% and above crumbled to fine pieces.  
 
4.1.2.5.2 Scanning Electron Microscopy Analysis 
As depicted in Figure 4.10, SEM analysis shows an obvious porous architecture at 1% 
µHA and a much less obvious porous structure in 2% µHA. At 4% µHA there was the 
absence of pores and the presence of what looked like layers within layers. 15% and 




















Figure 4.10: Scanning Electron Microscopy Images of 1% (w/v) Chitosan Scaffolds with 
Macroconcentrations of Micro-Hydroxyapatite. (A) 0g, (B) 1%, (C) 2%, (D) 4%, (E) 15%, and (F) 
20% (w/v) µHA. Pores are measured as depicted by red text. Images taken at x100 magnification. Pore 










4.1.2.6 Chitosan and Nano-Hydroxyapatite Scaffolds 
4.1.2.6.1 Gross Appearance 
Mixing nano-hydroxyapatite (nHA) into a 1% (w/v) CS solution resulted in solutions 
that increase in opaqueness with increasing nHA.  The opaqueness caused by using 
nHA was less than that caused by µHA. Once frozen, scaffolds looked translucent 
with a cream tinge. Once freeze-dried the scaffolds were cream colored, foam-like 
with a white periphery, and with no obvious difference between scaffolds (Figure 
4.9). Using a skin biopsy punch decreased in difficulty with increasing nHA 
concentrations and the samples were easily cut out with their shape retained. A 1-2 
mm layer of a white chalk-like material was formed on the base of the scaffolds with 
a small quantity remaining adhered to the culture plate as depicted in Figure 4.11 
where biopsy samples have been removed. This lead to the thought that the solutions 
must be saturated of nHA and that the concentration is overestimated. The most 
inferior layer of nHA could be easily broken away while the uppermost layers 







Figure 4.11: Chitosan Scaffolds with Various Amounts of Nano-Hydroxyapatite. 5 mL of 
1% CS (w/v) with various amounts of nHA was freeze-dried in each well of a 6 well plate. 
(A) 2.5%, (B) 3.0%, (C) 3.5%, (D) 4.0%, (E) 4.5%, (F) 5.0% nHA (w/v). Obvious punch 
biopsy retrieval shown is shown. There is a faint white substance on the well floor where 
biopsy samples are taken. 
Figure 4.11: Chitosan Scaffolds with Various Amounts of Nano-Hydroxyapatite. 5 mL of 1% CS (w/v) with various amounts of nHA was freeze-dried in each well of a 6 well plate. (A) 2.5%, 
(B) 3.0%, (C) 3.5%, (D) 4.0%, (E) 4.5%, (F) 5.0% nHA                                                                                    (w/v). Obvious punch biopsy retrieval shown is shown. There is a noticeable white substance on 
the well floor where biopsy samples are taken. 
4.1.2.6.2 Scanning Electron Microscopy Analysis 
Figure 4.12 shows a SEM analysis of a transversely cut scaffold illustrating a porous 
architecture. Pore openings were not obvious, with the walls collapsing inwards 
minimizing visualization. Cut pore walls look like frills. The 4.5% (w/v) nHA sample 
showed layers of CS rather than the required porous structure. However when nHA is 
increased to 5% (w/v) the porous structure remains. Pore size was difficult to quantify 















Figure 4.12: 1% Chitosan Scaffolds with Various Nano-Hydroxyapatite Concentrations. 5 mL of 
CS was freeze-dried in wells of a 6 well culture plate with various amounts of nHA. (A) 2.5%, (B) 3%, 
(C) 3.5%, (D) 4%, (E) 4.5% and (F) 5% nHA (w/v). Pore sizes are measured as depicted by red text. 











4.1.2.7 8% (w/v) Chitosan and Macroconcentrations of Nano-Hydroxyapatite 
4.1.2.7.1 Gross Appearance  
The mixing of these materials together resulted in viscous, cream colored solutions 
that were paler in comparison to 4.1.2.3. The nHA and CS dissolved sufficiently with 
a 1000 µL pipette tip. Freezing resulted in a substance similar to 4.1.2.3 and had a 
white inferior layer. Freeze drying resulted in a dense foam-like structure with a 
chalky base layer, the most inferior part easily broke away with the uppermost 
material left incorporated into the scaffold.  
 
4.1.2.7.2 Scanning Electron Microscopy Analysis 
As shown in Figure 4.13, SEM analysis reveals a porous structure. Visualization into 
the pores is obscured in some samples as the pore walls collapse inwards. Figure 4.13 
(A) below shows a rough surface with no porous or layered architecture. There was 


















Figure 4.13: Scanning Electron Microscopy Images of 8% (w/v) Chitosan Scaffolds with Various 
Nano-Hydroxyapatite Concentrations. 5mL of 8% (w/v) CS with various amounts of nHA was 
freeze-dried in a culture dish. (A) 2.5%, (B) 3.0%, (C) 3.5%, (D) 4.0%, (E) 4.5% and (F) 5.0%  nHA 











Using ImageJ software, an SEM image was binarised and threshold adjusted so that 
pores were white and chitosan was black. A filter was applied to remove small pixels 
of white. 30 pores were then measured from each of the 3 samples. Each of these 
different images is shown below in Figure 4.14. The average pore diameter was 
105.26 µm, 108.59 µm and 104.12 µm for each sample and is shown in Figure 4.15. 
There was no statistical difference between samples as analyzed by an ordinary 1-way 
ANOVA with a Tukey’s Multiple Comparisons Test (p <0.05). Table 4.1 shows the 






Figure 4.14: ImageJ Analysis of 8% (w/v) Chitosan and 5% (w/v) Nanohydroxyapatite Scaffolds. 
(A) shows untouched SEM image, (B) shows thresholded image in black and white, (C) shows filtered 



















Figure 4.15: Graphical Representation of Average Pore Diameters of Three Scaffold Samples. 
Scaffold sections were filtered with ImageJ and had pores measured. There was no statistically 
significant difference between all samples. 30 pore diameter was measured for three samples (n = 30, 
data points expressed as mean with error bars representing ± SE). 
 
 
Table 4.1: ImageJ Analysis of Scanning Electron Micrographs to Demonstrate Mathematical 
Parameters of Scaffold Pore Diameter. 
Parameter Sample 1 Sample 2 Sample 3 
Minimum 55.35 61.36 73.69 
25% Percentile 95.86 94.96 93.50 
Median 108.1 102.9 102.1 
75% Percentile 122.0 128.8 116.0 
Maximum 140.7 174.6 142.7 
Lower 95% CI of mean 97.13 99.29 97.33 


















4.1.3 8% (w/v) Chitosan and 5% (w/v) Nano-Hydroxyapatite Scaffold 
Characterization 
 
4.1.3.1 Micro-Computed Tomography of Scaffolds 
An 8% CS and 5% nHA (w/v) scaffold was chosen for µCT based on SEM results of 
pore diameter and the highest possible nHA concentration. The majority of pore sizes 
needed to be above 100 µm, to provide conditions compatible with cell migration. 
The highest concentration of nHA would provide optimal and additional bioactivity 
without loss of structural integrity. Open and closed porosity for 8% CS/5% nHA 
(w/v) scaffold are shown below in Table 4.2, with porosity results of a 5 and 10% CS 
with 5% nHA (w/v) scaffold shown for comparison. 
 
Table 4.2: CTan Porosity Analysis of 5, 8 and 10% (w/v) Chitosan and 5% (w/v) Nano-
Hydroxyapatite Scaffolds. 








0.0027 0.0202 0.0051 
Open porosity (%) 69.6 79.0 75.2 
 
 
4.1.3.2 Scaffold Rehydration and Stabilisation 
During rehydration in serial ethanol dilution, it was observed that particles from the 
scaffold would break off and be suspended in solution, or sink to the bottom of a 
falcon tube. After freeze-drying there was a ‘web’ of fibrous material that resembled 
cotton wool and surrounded the scaffolds and walls of the petri dish. This web was 
easily removed. During distilled water immersion the scaffold did not dissolve and 
indicated that the AA had been rinsed away. SEM results (Figure 4.16) show no 
obvious change in pore size with ethanol washing and immersion in distilled water. 





Figure 4.16: Scanning Electron Microscopy Images of Scaffolds Pre- and Post-Ethanol Series. (A) 
Shows a pre-ethanol series scaffold with appropriate pore sizes. (B) Shows a post-ethanol series 
scaffold with pore sizes still remaining appropriate. Frills of cut scaffold wall obscures view of several 
pores. Pores measured as depicted by white text. Images taken at x100 magnification. 
 
4.1.3.3 Scaffold Sterilisation  
Once autoclaving (121 °C for at least 20 minutes at 15 PPI) was completed the 
scaffold came out moist and a brown-orange color (Figure 4.17). SEM analysis 
(Figure 4.18) revealed appropriate sizes of porosity. Additional characterization of the 


















Figure 4.18: Scanning Electron Microscopy Image of an Autoclaved Scaffold. Pores measured as 
depicted by white text. Images taken at x100 magnification. 
 
4.1.3.4 Scaffold Degradation and pH Study 
Nine pre-weighed scaffolds were placed in phosphate buffered saline (PBS) and left 
in an incubator over several time periods. It was observed that there were particles of 
scaffold settling in solution. At each time point (48, 96 and 168 hours), 3 scaffolds 
were weighed after being freeze-dried. The average mass values were plotted on 
Prism 6 (GraphPad Software) against its original weight (t = 0 hours). Graphical 
representation is shown in Figure 4.19.  
 
Over a time period of 168 hours, there were no statistically significant differences 
between pre-degradation and post-degradation weights of all samples, as analyzed 
using a two-way repeated measure ANOVA with a Bonferonni’s post-hoc test, even 
though some scaffolds were observed to lose and even gain weight. 
 
The pH of PBS was measured with a pH meter and shown as a graph in Figure 4.20. 
The pH of PBS was originally 7.4 and was observed to decrease at 24 hours and 
remained consistent until 168 hours. This drop in pH ranges from 6.98 – 7.02, There 
was a significant difference between 0 hours and 24, 48 and 168 hours (p <0.001), as 
analyzed using a 1-way ANOVA with Bonferonni’s post-hoc test. No statistically 
significant difference was found between other hours. These statistical results are 
















Figure 4.19: Graphical Representation of Scaffold Degradation During Incubation. Columns 
indicate mass of samples pre- and post-degradation that have underwent various degrading periods. No 
statistically significant difference was found between columns (pre- vs post-degradation) as analyzed 
using a two-way repeated measure ANOVA with a Bonferroni post-hoc test (p > 0.05). Columns 













Figure 4.20: Graphical Representation of pH Change During Scaffold Incubation. Represents 
change in pH over 168 hours. There was a significant difference in pH between 0 and 24, 48 and 168 
hours p < 0.001). As analyzed using a one-way ANOVA with a Bonferroni post-hoc test  (n = 3, data 

































Table 4.3: Statistically Significant Differences in pH Across Incubation Periods of Scaffolds. (*** 
= p < 0.001, n.s. = no statistically significant difference). Analysis performed using a one-way 
ANOVA with a Bonferroni post-hoc test (n = 3). 
 
 0 hours 24 hours 48 hours 168 hours 
0 hours  *** *** *** 
24 hours ***  n.s. n.s. 
48 hours *** n.s.  n.s. 
168 hours *** n.s. n.s.  
 
 
4.1.3.5 Swelling Studies 
Nine scaffolds were immersed in PBS and left in an incubator for up to 168 hours. At 
each time point, scaffolds were removed and immediately weighed. It was observed 
that scaffold mass had increased with time and is graphically displayed in Figure 4.21. 
Sample 1 showed a statistically significant difference (P <0.01) between  0 hours and 
both 72 and 168 hours, and there was a significant difference (P <0.05) between 0 and 
24 hours. Sample 2 has a statistically significant difference between 0 and 168 hours 
(p < 0.01) and 72 hours (p <0.05). And in sample 3, there was a statistically 
significant difference between 0 hours and 168 hours (p <0.01), and 24 hours with 


























Figure 4.21: Graphical Representation of an Incubated Scaffold Swelling over 168 hours. Graph 
indicates change of mass of 3 scaffolds over time. As analyzed using a two-way ANOVA and 




































Table 4.4: Statistically Significant Differences in Swelling of Incubated Scaffold. Table A) 
sample 1, table B) sample 2, table C) sample 3.  These tables show if swelling was significantly 
different between incubation durations within each sample. As analyzed by two-way ANOVA 
with Bonferroni’s multiple comparison test (n = 6) (* = p < 0.05, ** = p < 0.01, n.s. = no 
statistically significant difference found). 
 
 0 hours 24 hours 72 hours 168 hours 
0 hours  * ** ** 
24 hours *  n.s. n.s. 
72 hours ** n.s.  n.s. 
168 hours ** n.s. n.s.  
 
 0 hours 24 hours 72 hours 168 hours 
0 hours  n.s. * ** 
24 hours n.s.  n.s. n.s. 
72 hours * n.s.  n.s. 
168 hours ** n.s. n.s.  
 
 0 hours 24 hours 72 hours 168 hours 
0 hours  n.s. n.s. ** 
24 hours n.s.  n.s. * 
72 hours n.s. n.s.  n.s. 
168 hours ** * n.s.  
 
4.1.3.6 Fourier Transform Infrared Spectroscopy  
Fourier transform infrared  (FTIR) spectroscopy was used to characterize the scaffold 
composition. The infrared spectra in Figure 4.22 showed strong PO4
3- (v2) bands 
appearing at 1092 cm-1 and at 1042 cm-1. The PO4
3-  (v1) band appeared at 962 cm
-1. 
Medium intensity CO3
2- bands were shown at 873 (v2) and 1421 (v2) and suggests that 
CO3
2- was incorporated in the HA lattice. There were typical chitosan absorption 
bands at 1654 cm-1 and 1595 cm-1 due to carbonyl (C=O) stretching and amine (N-H) 
deformation of CS molecules. The bands at 1319 cm-1 and 1378 cm-1 occurred due to  










Figure 4.22: Fourier Transform Infrared Spectroscopy of an 8% CS and 5% nHA scaffold. Peaks 
and bands labelled as shown. (A) 3423 cm-1 OH stretching, (B) 3100-3470 cm-1 broad OH stretching, 
(C) 2885-2990 cm-1 alipathic C-H stretching, (D) 1651 cm-1 amide I, (E) 1422 and 1461 cm-1 CO32-, (F) 
1380 cm-1 C-O stretching, (G) 1252 cm-1 free primary amino group, (H) 1030-1033 cm-1 PO43- 
stretching (I) 1030 cm-1 PO43-. 
 
 
4.1.3.7 Energy-Dispersive X-ray Spectroscopy  
Energy dispersive X-ray Spectroscopy (EDS) was done to further characterize the 
scaffolds, specifically their elemental composition. Results (Figure 4.23) indicated 
large sodium and chloride peaks followed by large carbon and oxygen peaks. Smaller 
peaks of phosphate, potassium and calcium followed this. Carbon and oxygen made 
up the majority of the scaffold with 51.18% and 23.44% respectively. Chloride was 
13.16% and sodium was 8.67%. Calcium was 2.1% with phosphate and potassium 







Figure 4.23: Energy-Dispersive X-Ray Spectroscopy of an 8% CS and 5% nHA scaffold. Peaks 
are labelled as shown with a table showing element, keV necessary for detection, mass (%) and error 
(%). Peaks demonstrate the number of counts (X-rays that are received and processed by the detector) 
and keV demonstrates the energy level of the counts that correspond to an associated element. 
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4.2 Cell Culture Experiments on 8% (w/v) Chitosan and 5% (w/v) Nano-
Hydroxyapatite Scaffolds 
4.2.1 Cell Viability LIVE/DEAD® Assay 
Growth media changed color from red to orange after 24 hours. There were no other 
observable differences between the 3 samples. Confocal microscopy revealed green 
ovoid shaped cells and irregular red cells. The fibroblastic morphology of the cell line 
was present at every time period, along with the presence of more ovoid cell shapes 
suggesting cells have not attached yet. Cell viability and total cell number was 
measured.  
 
For SAOS-2 cells cultured on scaffolds, the average cell viability at 24 and 48 hours 
were similar at 73%, with cell viability at 96 hours increased to 87%. The average 
total cell number was 43, 53 and 64 at 24, 48 and 96 hours respectively. These values 
are presented in Figures 4.24 (A) and (B) respectively, with statistical analysis results 
displayed in Table 4.5. LIVE/DEAD® assay images of the scaffold are shown in 
Figure 4.25 and were analyzed to acquire viability and total cell number results. The 
viability of cells at 96 hours had a statistically significant difference compared to 48 
and 24 hours. There was no statistically significant difference in viability between 48 
and 24 hours. 
 
For SAOS-2 cells cultured on coverslips, the average viability was 72, 81 and 97% 
for 24, 48 and 72 hours respectively. The average total cell number was 30, 33 and 58 
for 24, 48 and 72 hours respectively. Figure 4.26 shows the viability and total cell 
number results from the coverslip experiment. Table 4.6 demonstrates the statistically 
significant differences of viability and total cell number on a coverslip and only 
demonstrated a significant difference of viability between 96 and 24 hours. 
 
Figure 4.27 shows viability and total cell number comparison of scaffold versus 
coverslip.  There were no statistically significant differences between scaffold and 

































Figure 4.24: Graphical Representation of LIVE/DEAD® Assay of SAOS-2 Seeded 8% CS and 
5% nHA scaffold. (A) The average SAOS-2 viability (as a % of total cells, ± SE) over increasing 
culture time. (B) The average total cell number (±SE) over increasing culture time (n=3). Blue = 














































Table 4.5: Statistically Significant Differences of Viability and Total Cell Number Between 
Culture Periods Using a LIVE/DEAD® Assay on an 8% CS and 5% nHA scaffold. (* = p < 0.05, 
n.s. = no statistically significant difference) as analyzed using a one-way repeated measures ANOVA 
with a Bonferroni post-hoc test (blue = viability, red = total cell number) (n=3). 
 
 24 hours 48 hours 96 hours 
24 hours  n.s. * 
48 hours n.s.  * 























Figure 4.25: Confocal Micrographs of SAOS-2 Seeded Scaffolds. Green = live cell (calcein AM), 
red = dead cell (ethidium homodimer-1). (A) and (B) 24 hours. (C) and (D) 48 hours. (E) and (F) 96 
























Figure 4.26:Graphical Representation of LIVE/DEAD® Assay Using SAOS-2 Seeded Coverslips. 
(A) average SAOS-2 viability over increasing culture time (as a % of total cells, ± SE). (B) average 













































Table 4.6: Statistically Significant Differences of Viability and Total Cell Number Between 
Culture Periods Using LIVE/DEAD® Assay on Coverslips. * = p <0.05, n.s. = no statistically 
significant difference, as analyzed using a one-way repeated measures ANOVA with a Bonferroni 
post-hoc test (blue = viability, red = total cell number) (n=3). 
 
 24 hours 48 hours 96 hours 
24 hours  n.s. * 
48 hours n.s.  n.s. 






















Figure 4.27: Graphical Representation of LIVE/DEAD® Comparing Scaffold and Coverslip 
Viability and Total Cell Number. (A) The average SAOS-2 viability (as a % of total cells, ± SE). (B) 
The average total cell number (±SE). n.s. = no statistically significant difference found between test 
and control groups, as analyzed using a one-way repeated measures ANOVA with a Bonferroni post-
hoc test (orange = coverslip, green = scaffold) (n=3). 
 
4.2.2 CellTiter 96® AQueous One Solution Cell Proliferation Assay  
Scaffolds of CS/nHA and collagen were immersed in growth media to allow potential 
cytotoxins to leach out into the media in order to create a scaffold extraction vehicle. 
Vehicle is defined as a substance (growth media) to facilitate the use of another 

























































(0.01%) in growth media were used as media to grow cells. The MTS assay was a 
colorimetric assay to assess cell viability. It involved the tetrazolium dye MTT that is 
reduced to formazan by cellular enzymes, which reflected the amount of viable cells.  
 
It was observed that the yellow MTS gets increasingly purple as time progressed, 
especially in the chitosan and collagen wells. There was little change in colour of the 
yellow MTS of Triton-X vehicles. As shown by Figure 4.28, the absorbance reading 
of the Triton-X vehicle fluctuated around zero, and illustrates that there is very little 
to no enzymatic conversion of MTS to formazan and hence, no viable cells. The 
absorbances of both chitosan and collagen increased with time, illustrating that cells 
are proliferating and metabolizing MTS to formazan, with the highest absorbance 
values at 72 hours indicating higher amounts of formazan. This could indicate larger 
amounts of cells metabolizing MTS or cells have longer period to convert large 
amounts of MTS. There was no statistically significant difference between the 
chitosan and collagen extraction vehicles, as collagen is considered to be non-toxic it 
is implied that chitosan has no negative affect on cell proliferation. There was a 
statistically significant difference between Triton-X and chitosan absorbances at 0 
hours (p <0.05) that indicates absorbance readings of formazan, media buffer, or 


























Figure 4.28: Graphical Representation of Vehicle Absorbances Using MTS Assay. Line graph 
shows absorbance reading of CS, collagen and Triton-X vehicles over 72 hours. Absorbance = mean ± 
SE. There were statistically significant differences between Triton-X and both Collagen and Chitosan 
at 24, 48 and 72 hours (p < 0.001). There was a statistically significant difference between Chitosan 
and Triton-X at 0 hours (P <0.05). There was no statistically significant difference between Collagen 
and Chitosan at all time points( n=3). 
 
4.2.3 Three Dimensional SAOS-2 Cell Culture 
4.2.3.1 Histology of SAOS-2 
Figure 4.29 shows light microscopy images of haematoxylin and eosin (H&E) stained 
test and control scaffolds, and an image of a seeded coverslip that were all cultured 
for a time period of 14 days. The porous nature was evident by the sectioning of the 
scaffold, with ‘clumps’ of CS forming thick and thin walls. In both test and control 
images chitosan was shown to stain pink by eosin. In the test scaffold (A) and (B) 
there were light-pink stained structures found throughout the CS thought to be nHA 
(arrowhead), which indicates that nHA is acidic or positively charged allowing 
staining by eosin. Haematoxylin stained structures were found throughout the scaffold 
and were stained purple (arrows). These structures varied in shape and size and 
location. They concentrated in the top quarter of the scaffold and were dispersed 
throughout the entire scaffold but were less concentrated or found as singular entities. 
Image F demonstrated H&E staining of a coverslip, with purple nuclei and pink 
cytoplasm. Figure 4.30 shows a light micrograph of an H&E stained scaffold using 




























Figure 4.29: Haematoxylin and Eosin Stained Scaffold and Coverslip containing SAOS-2. (A) 
Test x10 objective, (B) test x20 objective with cellular structures (arrow) and hydroxyapatite 
(arrowhead), (C) control x10 objective, (D) control x20 objective, (E) glass coverslip x10 objective, (F) 











Figure 4.30: Fluorescent Microscopy of Haematoxylin and Eosin Stained Scaffold containing 
SAOS-2. Yellow fluorescence indicates CS and green indicates cells. Image taken at x20 
magnification. 
 
Figure 4.31 shows light microscopy images of Masson’s Trichrome (stains collagen 
blue, cell nuclei blue-black, and cytoplasm orange-red) stained test and control 
scaffolds, and an image of a seeded coverslip that were all cultured for a time period 
of 14 days. The CS matrix was stained a dark purple/red in Images A-D and was 
darker in Images A and B. Image A and B revealed pink and blue structures that 
corresponds to nHA (arrowhead) a cellular structure (arrow) respectively, that was 
similar to that found in H&E staining. Image E and F demonstrated staining of a 









Figure 4.31: Masson's Trichrome Stained Scaffold and Coverslip containing SAOS-2. (A) Test 
scaffold x10 objective, (B) test x20 objective, with a cellular structure stained blue (arrow) and 
hydroxyapatite stained pink (arrowhead), (C) control x10 objective, (D) control x20 objective, (E) glass 










Figure 4.32 shows light microscopy images of Alizarin Red stained test and control 
scaffolds, and an image of a seeded coverslip that were all been cultured for a time 
period of 14 days. Image A–D revealed a lightly red stained CS matrix, with A and B 
staining slightly darker. Image B revealed a cell structure similar to that found in 
H&E staining (arrow). Images E and F revealed clusters of dark red staining, with cell 




























Figure 4.32: Alizarin Red Stained Scaffold and Coverslip containing SAOS-2. (A) Test x10 
objective, (B) test x20 objective with cell cluster (arrow), (C) control x10 objective, (D) control x20 










Figure 4.33 shows light microscopy images of Von Kossa stained test and control 
scaffolds, and an image of a seeded coverslip were all been cultured for a time period 
of 14 days. Image A and B revealed a red stained CS matrix due to Van Gieson 
counter staining and black specks throughout the matrix that corresponds to Von 
Kossa staining of calcium deposits. Image B showed a structure similar to the cells 
found in H&E staining and has black specks within (arrow). In Images C and D there 
were no black stained structures, as there are no cells or nHA. Images E and F 
revealed specks of black found in the cell cytoplasm. Image G showed areas of black 

































Figure 4.33: Von Kossa Stained Scaffold, Coverslip containing SAOS-2 and Prostate Control 
Section. (A) Test x10 objective, (B) test x20 objective with an arrow pointing to a cell cluster 
containing black stained structures, (C) control x10 objective, (D) control x20 objective, (E) glass 
coverslip x10 objective, (F) glass coverslip x20 objective, (G) control human prostate x4 objective with 
black stained regions (arrows). 
 
Figure 4.34 shows light microscopy images of Van Gieson stained test and control 
scaffolds, and an image of a seeded coverslip that were all been cultured for a time 
period of 14 days. Van Gieson stained for blue/black nuclei, red collagen and yellow 
muscle. Images A-D revealed that CS is stained red. Image B revealed a structure 
(arrow) that was stained red but not as intensely as CS. This structure had a similar 
appearance to the cells found in H&E staining. In Image A, lightly stained regions 
were found through the CS matrix (arrow) and corresponded to nHA. These regions 
were not found in Images C and D. Image E and F showed that both the nucleus and 
cytoplasm are stained red, with the nuclear contents staining darker red or black. This 













Figure 4.34: Van Gieson Stained Scaffold and Coverslip containing SAOS-2. (A) Test x10 
objective with arrow pointing to nHA, (B) test x20 objective with arrow pointing to cell cluster, (C) 
control x10 objective, (D) control x20 objective, (E) glass coverslip control x10 objective, (F) glass 










4.2.4 Bone Marrow Cell Culture 
Observation by phase contrast microscopy 24 hours after plating marrow showed a 
heterogeneous population of cells, where certain populations were elongated and 
spindle shaped, while the other was polygonal or flat shaped with little to no 
processes. Following protocol, cells were passaged at day 3 even though it was not 
70-80% confluent but was approximately 40-50%. This resulted in the appearance of 
the spindle and polygonal cell populations that attach but had a reduced ability to 
proliferate. The second and third passage took a large amount of time to become 
confluent so passage was not done at 70-80% confluency, but was approximately 20-
30%. These passaged cells were found individually or in small clusters of 2-3 cells 





Figure 4.35: Phase Contrast Micrographs of Bone Marrow Cell Populations. (A) spindle cell and 
















5.1 Scaffold Manufacture  
The aim of this thesis was to fabricate a chitosan (CS) and hydroxyapatite (HA) 
scaffold, with pore diameters greater than 100 µm and porosity similar to bone. These 
requirements allow cell attachment, migration and fluid transport. Additional 
characteristics of the scaffold were bioactivity to promote boney integration and 
ingrowth; and biocompatibility so there is no immune response or cytotoxicity.  When 
this scaffold was 3D cultured in a bioreactor (providing shear stress and a circulation) 
a further aim was to produce a 3D sample of osteoid tissue. 
 
5.1.1 Primary Scaffold Manufacture 
The inaugural development of a scaffold was unsuccessful as indicated by data and 
gross observation.  Scaffolds were mechanically weak and the majority was 
comprised of a layered structure and therefore is incompatible with cell culture. 
 
Our findings in Figure 4.5 demonstrated that freezing scaffolds at -80 °C resulted in a 
layered architecture following freeze-drying. This means that the scaffolds will not be 
able to support cell growth, as there is the absence of a porous architecture. In a study 
by Cooney et al., the freezing of CS solutions below -50 °C resulted in a layered 
architecture and illustrated that mass transfer (concentration gradients) dominates the 
system. As the author’s scaffold was frozen at -80 °C, it was clear that the scaffolds 
were governed by mass transfer during freezing, and when combined with SEM 
analysis, the layered architecture is evident (60).  
 
Initially only scanning electron micrography (SEM) was performed but this only 
provided a limited view of the entire scaffold, which may have missed structural 
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differences that appeared in other locations. To garner a greater appreciation, several 
SEM images of different locations (from superior to inferior and medial to lateral) 
should be taken. For improved visualization we used micro-computed tomography 
(µCT) to analyze the entire structure of one biopsy sample, giving approximately 
1000 image slices that confirmed layers throughout. These images could be analyzed 
with software to calculate pore size and porosity. However with µCT, processed 
images can give inaccurate estimations, as thresholding can reduce or increase pore 
size, and modify pore walls that could be analyzed as non-pore. As this was only a 
small 3 mm biopsy sample from the larger sample made in the wells, there could very 
well be different architectures throughout the samples in the wells.  µCT imaging, 
although provided a comprehensive view of one small sample, is limited by the fact it 
cannot image larger samples and is time consuming, taking several hours for one 3 
mm sample at a medium camera resolution.  
 
Results indicated by Figure 4.1 that increasing the CS concentration caused the 
severity of cracks or fissures and the layered architecture to become more extensive, 
and that there was an increasing amount of air bubbles becoming trapped in solution. 
This demonstrated that increasing the concentration of solute altered the physical 
properties during scaffold development. Work by MacKenzie demonstrated that 
solutes retained water during the freeze-drying process so when secondary drying 
commences, these solutes shrank and generated stresses causing cracks (76). Our 
findings suggested that increasing solutes resulted in a larger amount of water 
retention, and therefore produced larger stresses and cracks.  Another reason for the 
appearance of fissures may be due to the freezing process. Water froze from the 
outside in, expanding upward in its confined container. As water in the central portion 
of the well freezes it will expand and generate stresses on the peripheral ice, causing it 
to crack and allow its expansion. Alternatively, it may be possible that the cracks are 
formed by large ice crystals that extend across the well, so when lyophilized, it leaves 
a sharp groove surrounded by CS. 
 
Increasing the CS concentration (up to 3.5% (w/v)) resulted in an increasingly viscous 
gel that retained air bubbles due to mixing. After resting overnight these bubbles rose 
to the surface and disappeared with bubbles in the least viscous gels disappearing 
first.  This was important, as air bubbles that remained in the frozen scaffold would 
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introduce inappropriately sized pores during the freeze-drying process. Additional 
studies involving the introduction of bubbles into solution may be an alternative 
method of introducing pores. This may be beneficial for highly viscous solutions that 
will not let bubbles escape. 
 
The fissures and the peripheral porous region appeared at random locations and were 
of varying sizes. There must have been heterogeneous ice nucleation conditions 
within and around each sample. Possible reasons for this would have to alter the 
thermal gradient (ΔT) and hence heat or mass transfer (60). Plastic is a poor 
conductor of heat so the periphery of each sample is in contact with a well wall and 
will have a slower freezing rate compared to the material in the center. This 
occurrence was observed by Stace 2011, who froze scaffolds at -80 °C in plastic wells 
which resulted in porous peripheral regions and layered central regions (39). However 
this would not explain why these peripheral regions appear randomly. Alternative 
explanations may involve what is in contact with the well plates: air, freezer wall, and 
other frozen objects that can increase or decrease ΔT. Future studies should look into 
creating homogenous freezing conditions for samples in order to generate 
homogenous scaffolds, such as freezing in liquid to create the same temperature 
surrounding the CS gels. 
 
Cooney et al. explained the presence of a smooth surface on top of every sample, 
which is shown by Figure 4.2 (A, arrow). A solution exposed to air in the freezer 
formed a ‘skin’ at the initial air-liquid interface that caused significant resistance to 
heat transfer. This resulted in an even ice crystal formation at the beginning of the 
freezing process (60). This skin also appeared between the scaffold-well interfaces. 
This layer of CS was non-porous and must be removed prior to cell culture, as it is a 
barrier for cellular migration. Additional work should look into the interfaces between 
the CS gel and the surrounding wells and air so that this skin does not form and is 
porous all the way through. This will have to investigate the various conductances of 
materials. 
 
A study by Madihally froze scaffolds at -78 °C and this resulted in the formation of 
pores whereas the author’s did not. In contrast, the methods showed that scaffolds 
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were produced at 1 and 2% (w/v) CS with 1.2% (v/v) AA inside pre-cooled, flat 
bottomed glass tubes with a diameter of 1.5 cm and 1.2 mm wall thickness. These 
tubes of 3-5 mL of solution were frozen in liquid at specified temperatures. This study 
illustrated that smaller diameter scaffolds in high conductance materials (compared to 
plastic that the author used) that is in close contact with surrounding temperature can 
still result in the formation of pores that averaged to be 140 µm for 1% and 90 µm for 
2% (w/v) CS. This supports the idea that the conductance of materials can have 
significant effects on the rate of freezing and pore formation. 
 
5.1.2 Secondary Scaffold Manufacture 
In order to generate a porous scaffold, freezing conditions (such as temperature and 
duration), and container shape were altered. The development of a porous scaffold 
was successful as indicated by data, however, scaffolds were still mechanically weak 
and lacked bioactivity. 
 
5.1.2.1 Freezing Studies 
Findings as shown by Figure 4.4 indicated that freezing scaffolds at -22 °C resulted in 
a porous architecture and that -80 °C resulted in a layered architecture. Increasing the 
freezing time appeared to elongate pore diameter and increase the extensity of fissures 
and layers.  
 
Freezing scaffolds at -22 °C in concordance to a mass transfer governed system 
(temperature greater than -50 °C) resulted in spherical ice crystal growth and thus, 
once freeze-dried we were left with pores (60).  This means that freezing at higher 
temperatures and/or providing a small thermal gradient caused pore formation. 
Several studies indicated that freezing at -20 °C resulted in a porous architecture 
(59,71–73). Between these studies and the author’s, similarities in scaffold 
preparation to post-freeze-drying include CS concentrations, AA concentrations, and 
temperatures of freezing. Differences include additives (calcium nitrate, ammonium 
phosphate) to produce HA in situ, and treatment by NaOH post-freeze drying to 
neutralize the AA. From this evidence we can suggest that temperature is the main 
determinant in whether layers or pores form.  
 
 104 
Increasing freezing times appeared to elongate pore diameters as shown by Figure 
4.5. This indicated that pore dimensions are dependent on freezing time and results in 
the formation of pores that are not a sphere-like shape. In a study by Cooney et al., 
freezing beyond a certain time point resulted in pores that became longer in diameter 
that also became less interconnected. Pawelec, Husmannm Best & Cameron 
suggested that a longer freezing duration resulted in the preferential growth of large 
ice crystals due to the constant remodelling and annealing of ice (61). A possible 
explanation for elongated pores may be due to the thermal gradient. Instead of ice 
forming in the direction of the gradient ice may remodel in this direction resulting in 
elongated pores. Pores should be measured at more freezing points to determine if 
there is a point at which pores begin changing dimensions, and whether freezing 
should be halted and the scaffold be put through immediate freeze-drying. Additional 
study should look into the geometry of the pores and the influence of this on live 
cells. It was found by Bidan et al. that cross shaped pores resulted in twice the amount 
of ECM deposition compared to square shaped pores (74). A study by Ripamonti 
illustrated the effects of highly crystalline biomimetic matrices on bone formation. It 
was demonstrated that a specific geometry induces the formation of bone by the 
anchorage of endogenous BMP and other growth factors (75). Looking into the 
effects of ovoid pores and other geometries on cells should be investigated as these 
can optimize osteoid production. 
 
At 72 hours of freezing time, the author’s scaffold showed elongated pores when 
frozen at -22 °C, whereas Cooney et al.’s scaffold had a layered architecture at -20 
°C. Both samples were of similar volumes but different shapes. The author’s scaffold 
was cylindrical; Cooney’s was a rectangular prism and therefore, had a greater surface 
area for heat transfer. Cooney’s scaffolds were also made in metal molds adding to 
the propensity of a higher heat conductance. The greater surface area and metal molds 
may explain the reasoning as to why layers were present when Cooney’s scaffold was 
frozen at -20 °C. This further supports the notion that small thermal gradients or slow 
heat transfer results in pores (60). 
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5.1.2.2 Container Studies 
Figure 4.6 indicated that the container the CS solution was frozen and freeze-dried in 
had no influence on pore formation. Different containers frozen at -22 °C and -80 °C 
showed the characteristic porous and layered architecture respectively. The sample 
frozen in a transfer pipette was expelled during the freeze-drying process and could 
not be used for analysis. 
 
In contrast to the author’s study, a study by Madihally and Matthew demonstrated the 
production of radially oriented pores that were larger and elongated towards the 
center, with smaller, interconnected pores in the periphery when scaffolds were 
produced in cylindrical containers. Scaffolds that were produced in a shallow square 
dish resulted in uniform and perpendicular pores to the container dimensions (72). 
This demonstrates that the thermal gradients acting on the container play a role in 
pore shape. The three-dimensional nature of the thermal gradients must be taken into 
account, as heat is lost from the center to the periphery, and therefore the scaffold will 
not be homogenous throughout. Similar to the peripheral/central structural differences 
in the cylindrical container by Madihally and Matthew, freezing scaffolds (as 
previously discussed) at -80 °C produced a peripheral porous material and a layered 
center.  It is possible that pores formed initially and elongated substantially to become 
layers when exposed to strong thermal gradients or for long periods of time  
 
The limitation exists in the author’s study, that SEM imaging only takes a single view 
at one location and therefore, will not be able to detect patterns in pore architecture. 
The author suggests that SEM analysis be performed from the periphery to the center 
of an entire freeze-dried sample in order to see if there is a pattern in pore formation. 
 
5.1.3 Chitosan and Hydroxyapatite Scaffold Manufacture 
5.1.3.1 Micro-Hydroxyapatite 
Micro-hydroxyapatite (µHA) was added to produce a composite scaffold with CS that 
is bioactive and has enhanced structural integrity. Figure 4.9 indicated that the 
addition of µHA resulted in reductions in pore diameter, the development of layers 
and reduced structural integrity. At minute amounts, µHA saturated the solution and 
excess settled on the well floor. Very little HA dissolved with the excess floating in 
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solution or settling, so once freeze-dried the little that have dissolved precipitates with 
the floaters and settlers drying out and dispersed among the chitosan. At very large 
amounts, the freeze-dried scaffold was friable and collapsed with agitation. 
 
The addition of increasing amounts of µHA resulted in reductions of pore size. This 
means that there was a limit on the amount of µHA you can add before pore sizes 
were inappropriate. However, we were not able to reach this limit as the structure 
instead became layered and weak. Comparable to Cooney et al., the addition of 
solutes may have altered thermal conductivity and viscosity resulting in smaller pores. 
A possible explanation of these layers may be, once again, the altered thermal 
gradient, that converted pores to a layered structure.  
 
As bone is comprised mostly of minerals (~70%), it was thought that higher 
concentrations of HA could be used. However, 4% µHA and above when combined 
with 1% (w/v) CS resulted in friability of the scaffold as demonstrated in Figure 4.10, 
where the absence of pores was due to a broken sample. MacKenzie demonstrated 
that the solute matrix collapses during freeze-drying due to water vapor damaging the 
structural integrity. This indicated that there are no interconnections between layers or 
pores in the scaffold and therefore is incompatible with tissue engineering (76). 
However, bone is also comprised of an organic component (30%). Therefore, a higher 
amount of CS may be necessary to form the solute matrix to support µHA. Other 
studies involving collagen have used up to 60% collagen and 40% (w/v) HA, 30% 
collagen and 70% (w/v) HA, and 5% collagen and 70% (w/v) HA and exhibited no 
friability (77,78).  This indicated that collagen might be of superior structural integrity 
to CS. Future work may involve the addition of collagen to chitosan and 
hydroxyapatite scaffold to improve the inherent weak strength. 
 
5.1.3.2 Nano-Hydroxyapatite 
Results from Figure 4.12 indicated that the produced composite scaffolds (1% CS 
with varying nHA) were porous. These scaffolds had a higher structural integrity than 
previously made scaffolds made with µHA. 
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Compared to µHA, nano-hydroxyapatite (nHA) particles are of the nano scale and 
have a greater surface area to volume ratio (79). Pore measurements ranged 46.0 – 
223.2 µm, it was expected that the addition of nHA would reduce pore diameter, but 
this was not obvious with SEM analysis. This means several things: further nHA can 
be added without the reduction of pore diameter, additional imaging studies are 
needed, or nHA is insoluble with very little dissolution of ions into acidic solution 
(compared to dissolved chitosan that when increased, pore diameter would reduce). 
There was a faint white surface on the base of the well under where a sample has been 
taken (Figure 4.11) and a small layer of nHA on the base of every scaffold. This 
indicated that calcium and phosphate has saturated the solution with the excess nHA 
settling to the bottom of the well. Other studies have shown greater amounts of added 
HA, a 2% (w/v) CS and 12% (w/v) nHA scaffold was prepared in situ by Kong. 
However, pore sizes were 20 – 60 µm ranges and deemed unsuitable for cell culture 
(59).  Several studies show that nHA added to CS does not influence the porous 
structure or significantly affect porosity. Instead, only the microscopic morphology of 
the CS surface was different, where nHA particles were “scattered like islands” 
homogenously throughout (71,79). This means that further nHA can be added without 
changing the structure. However, the settling of nHA at the bottom of the well 
indicates rapid saturation of the solution by calcium and phosphate ions and/or that 
nHA is not very soluble. This layer of nHA would be wasteful. 
 
Biopsy sampling was easily made with no friability exhibited and is demonstrated in 
Figure 4.11. Previous studies have shown that addition of nHA to scaffolds resulted in 
an increased compressive modulus (79). This further supports the use of HA as part of 
the composite scaffold. Combined with this improved structural integrity, nHA is 
similar in size to HA found in bone and shows significant increases in protein 
adsorption and cell adhesion. Therefore, nHA is a suitable ceramic for the production 
of CS composites. 
 
Future work should look into introducing nHA into solution that allows significantly 
greater amounts to dissolve and integrate with CS. This may involve in situ 
precipitation, increasing temperature, or increasing the available surface area of HA. 
Once a suitable scaffold has been finalized, mechanics testing should be investigated 
to compare compressive and tensile strength to that of bone. 
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5.1.4 Macroconcentrations of Chitosan 
Our findings in Figure 4.8 suggest that increasing CS concentration to 10% (w/v) and 
above results in pore diameters beginning to fall below 100 µm. Increasing CS 
concentration produces dense, foam-like scaffolds with higher structural integrity to 
what was made previously.  
 
This indicated that the methods used to freeze and freeze-dry scaffolds allowed the 
use of higher concentrations of CS. The majority of current literature used chitosan of 
concentrations 1, 2, 3 g/100 mL or percent (w/v) as further increases in CS results in 
reductions in pore size. (56,59,60,72). However, a study by Jana et al. developed 
scaffolds up to 12% (w/v) CS. The differences between this method and the authors 
were centrifuging prior to freezing to remove air bubbles, freezing the solution in 10 
mL syringes at -20 °C for 24 hours, and lyophilization at -89 °C until dried. This 
resulted in highly interconnected porous scaffolds with pore size ranging from 100 – 
500 µm, porosity of 86.1% at 12% (w/v) CS and high structural integrity (73). 
However this scaffold lacked bioactivity and needed the addition of HA. Jana et al. 
emphasized the duration of CS dissolving in weak acid prior to freezing (similar to 
the author’s, which was at least 24 hours) as protonation of the amine groups of CS 
was difficult to occur completely. This allowed protonation to increase with time and 
resulted in rigid CS chain conformation and viscosity of solution, and hence high 
structural integrity of the scaffold. Cooney et al. showed that increasing CS 
concentrations did not significantly affect pore structure even though the scaffold was 
denser. This suggested that ice crystal growth was not affected by CS concentration at 
-20 °C. However, this observation occurred at 1, 2, and 3% (w/v) CS hence there 
might be significant changes at higher concentrations (60). The clinical implications 
of being able to use high concentrations of CS may allow the development of a high-
strength bone graft substitute that may be able bear weight or maintain its integrity in 
vivo and therefore expanding the use of CS as a bone tissue engineering material. 
 
Additional studies around manipulation of CS concentration, freezing temperature 
and time, and lyophilization conditions might help determine the optimum conditions 
for appropriate pore size and porosity. It is recommended that repeating a 12% (w/v) 
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CS scaffold using the method developed by Jana et al. with nHA for increased 
bioactivity and to determine nHA effects on pore size. 
 
5.1.5 8% (w/v) Chitosan Scaffolds with Macroconcentrations of nHA 
Now that scaffolds with appropriate pore size and structural integrity have been 
produced, bioactivity can be increased by the addition of nHA. Composite scaffolds 
were made based on the 8% (w/v) CS scaffold as pore sizes were well above 100 µm. 
So when nHA was added pore sizes could reduce yet still be above 100 µm. SEM 
imaging revealed that all nHA concentrations resulted in pore sizes that appeared to 
be above 100 µm. 
 
SEM data as shown in Figure 4.13 indicated that the addition of nHA (2.5 – 5% 
(w/v)) to 8% (w/v) CS solution resulted in pores that ranged from 22.7 – 414.3 µm in 
diameter. This means that the added nHA appeared to have no influence on pore 
diameter, supporting the above notion in 5.1.3.2.  
 
This may be due to the limited dissolution of calcium and phosphate ions in acetic 
acid, so nHA remains immiscible and suspended in solution. In comparison to 
dissolved chitosan in acetic acid, increasing concentration resulted in reduced pore 
diameters. During preparation of the scaffold in the mixing step, nHA was suspended 
in solution causing it to become pale or it would settle to the bottom, indicating nHA 
is not very soluble. After freeze-drying a layer of white substance accumulated at the 
base of each well and suggests further settling of HA during the freezing process. This 
was a 1-2 mm thick and further indicates that nHA does not dissolve fully. 
 
Additional study can investigate the actual weight of nHA in the scaffold (not 
including the white layer base) and whether nHA dispersion is homogenous 
throughout. Modifications to the protocol must be made to ensure homogenous 




5.1.5.1 Pore Diameter Analysis By Scanning Electron Microscopy of 8% (w/v) 
Chitosan and 5% (w/v) Nano-Hydroxyapatite Scaffold  
As shown in Figure 4.15 and Table 4.1, tt was found that the average pore diameters 
were above 100 µm in all 3 samples, with 95% confidence intervals as follow: 97.13 -
113.4 µm, 99.29 – 117.9 µm, and 97.33 – 110.9 µm for samples 1, 2 and 3 
respectively. The smallest pore diameter measured was 55.35 µm and the largest was 
176.4 µm. There was no statistically significant difference found between pore 
diameters in the 3 SEM image samples. This indicated that the average pore diameter 
is suitable for tissue culture in 3D, however, even though the average diameter is 
suitable fore cell culture, some pores are well below the appropriate diameter and 
therefore will not be suitable for cells. 
 
Figure 4.15 indicated homogeneity between samples and therefore throughout the 
scaffold, as pore diameters were not statistically significantly different from one 
another. However, bias ensued due to the selection of SEM images, where clear pore 
outlines were necessary for accurate measurement. Other images taken for pore 
analysis had obscured pores due to unsuitable sectioning or walls collapsing inward. 
These unsuitable images may represent variation in pore sizes that deviated from 
those measured. As measurements were taken from one plane through a pore, it is 
unknown whether the measurement was taken at its largest or smallest axis and 
therefore will provide an inaccurate measurement of the largest pore diameter. There 
was also selection bias of pores for measuring. While care was taken to measure all 
available pores, very small ‘pores’ were not measured, as they may be artifacts from 
image processing. By comparing the original and processed image, it is evident that 
converting a 3D image to black and white binary produces false pores. So selection 
criteria involved restricting pores less than 50 µm to decrease this bias.  
 
The use of automated imaging software for pore size was not pursued as analysis 
resulted in incorrect data, as pore diameter measured was an average of 10 µm that 
clearly does not correlate to the large pore sizes found on SEM and µCT imaging.  As 
pore sizes are varied and are not all above 100 µm, this may negatively impair cell 
growth. Although the average is acceptable, there are several pores that will not be 
involved in cellular proliferation and migration. Therefore this would result in non-
homogenous cell growth and ECM (osteoid) production throughout the scaffold. 
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However, as the scaffold degrades in vivo the smaller pores will coalesce to form 
larger pores that will be optimal for cell migration, fluid transport, neovascularization 
and osteogenesis. 
 
µCT imaging may be improved if recorded using high camera pixel settings to 
improve the definition of pore walls. Freezing of scaffolds may provide another way 
of processing for image analysis, to improve pore wall strength during sectioning. 
Depending on availability, it is recommended to use the widely used mercury 
intrusion porosimetry as a way to calculate pore size and porosity (59,73). 
Modification of the scaffold may need attending to in order to increase the size of all 
pore diameter to be above 100 µm. 
 
5.1.5.2 Porosity Analysis By Micro-Computed Tomography of 5, 8 and 10% 
(w/v) Chitosan and 5% (w/v) Nanohydroxyapatite Scaffold  
SkyScan software analyzed the interconnectivity between pores and was 69.6% in 
5%CS/5%nHA (w/v), 79.0% in 8%CS/5%nHA (w/v) and 75.2% in 10%CS/5%nHA 
(w/v) as shown in Table 4.2. The trend in Table 4.2 showed an increase in porosity 
from 5 to 8% then reduced when increased to 10%. These results suggested that the 
porosity of both 8 and 10% (w/v) CS was appropriate for tissue engineering. As 
cancellous bone had a porosity 70% or greater, allowing adequate nutrient and waste 
exchange we deemed any porosity comparable to this suitable (80). A possible 
explanation for why 5% (w/v) CS had a low porosity may be freezing times. Although 
all scaffolds were frozen for at least 24 hours, freezing times may vary for each batch 
(frozen longer than 24 hours). As explained before, lengthened freezing time may 
cause greater interconnectivity but beyond this interconnectivity will decrease as ice 
crystals anneal (61). Work by Jana et al. opposed the porosity trend demonstrated by 
the author’s study. The study showed high porosities for all samples that decreased as 
CS concentration increased. This suggested that the temperature of -20 °C and 
duration of freezing of 24 hours was ideal to provide highly interconnected pores 
(73).  
 
Strengths of the porosity analysis by µCT included the analysis of an entire sample as 
µCT provided approximately 1000 images. However this sample was only 3 mm and 
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came from one region of the prepared sample in a well plate. This may have 
porosities different from other locations in the well. Limitations included the 
processing of the images to calculate porosity. Processing involved conversion to 
binary and involved altering pore wall boundaries slightly to remove artifacts. This 
may have provided inaccurate porosity measurements, as some continuous walls may 
break and be detected as interconnected. The limitation exists that only 1 sample of 
each CS concentration was analyzed, therefore we could not do any statistical 
analyses.  Additional study can investigate what freezing temperatures and times 
result in optimal porosity. As stated in 5.1.5.1, mercury porosimetry may be of use to 
calculate porosity. 
 
5.1.6 Scaffold Characterization 
 
5.1.6.1 Scaffold Rehydration and Stabilization 
After freeze-drying we were left with precipitated polymers of chitosan acetate that 
when introduced to aqueous media, will liberate acetic acid and re-dissolve the 
scaffold. Ethanol wash series removed acetic acid without impairing structural 
integrity or pore structure. Initially a few particles were visibly floating in solution. 
The final wash in distilled water resulted in an intact scaffold with no dissolving. 
SEM analysis as shown by Figure 4.16 revealed no observable differences in structure 
and indicates an ethanol wash series is suitable to remove aqueous acetic acid.  
 
There was a variety of ways to remove acid, including: sodium hydroxide, sodium 
sulfate, tripolyphosphate and the attempted ethanol series. These deprotonate the 
amine group on chitosan and promote cross-linking (12). Studies have demonstrated 
that hydration with NaOH causes some shrinkage and distortion due to alkalinity 
induced changes to CS crystallinity, and that partial reversal of this change was 
observed at pH 7 solutions. Using ethanol series caused no significant volume or 
shape changes, and allows complete hydration. This could provide another way of 
sterilization using 70% alcohol, and equilibrated using media prior to cell culture 
experiments (72). Care must be taken not to use concentrated aqueous NaOH 
treatment and/or alcoholic NaOH with exposure to oxygen as this promoted further 
deacetylation (57) and cytotoxicity to cells. However, many studies used mild NaOH 
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as a neutralizer and do not report any structural irregularities (59,71,73). Therefore 
this indicated that mild NaOH or an ethanol series are appropriate for removing acid. 
 
5.1.6.2 Autoclaved Scaffolds 
As shown by Figure 4.17, orange colored scaffolds came out of the autoclave with the 
nHA still attached to the inferior layer. Autoclaving did not appear to have significant 
effects on structure with SEM analysis revealing pore sizes to be greater than 100 µm. 
This means that autoclaved scaffolds may be potential candidates for tissue 
engineering.  
 
A study by Ji & Shi showed that autoclaving was an efficient method of sterilizing 
and caused thermal cross-links that increased the compressive modulus of a CS 
scaffold. A viability and proliferation assay demonstrated that autoclaving resulted in 
a biocompatibility scaffold with no formation of toxic products. Additionally, pores 
were homogenously distributed (81).  Although the author decided not to use an 
autoclaved scaffold, the scaffold had potential for tissue engineering as sterilization 
was efficient and cross-links improved its integrity. Additional study should test 
cytocompability of an autoclaved scaffold with nHA to determine if cell viability or 
proliferation could be improved and whether it is superior to a non-autoclaved 
scaffold. 
 
5.1.6.3 Scaffold Degradation and pH Study 
Figure 4.19 indicated there was no statistically significant weight change over the 
incubation period of up to 7 days but there was a significant change in pH over this 
time period as shown by Figure 4.20. 
 
These results (Figure 4.19) supported that scaffolds do not degrade significantly in 
vitro or at simulated physiological conditions, and will retain structural integrity at the 
implantation site. Therefore physiological temperature and buffered solutions did not 
affect degradation. However, this was not a true representation of a physiological 
system, as the scaffold will be exposed to mechanical forces of perfusion and cellular 
waste products that may degrade it.  Realistically, scaffolds would be implanted for 
longer than 7 days and therefore should be in conditions similar to in vivo. 
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Additionally, mammals do not possess chitosanases and therefore lysozyme is the 
primary enzyme to degrade the scaffold (82). It may be appropriate to place scaffolds 
in buffer containing physiological amounts of lysozyme and look into developing 
predictable degradation rates.  
 
Results (Figure 4.20) from pH measurements indicated a statistically significant 
difference (Table 4.3) in pH (7.42 lowers to 6.98-7.02) between time 0 and 24, 48 and 
168 time points. This implied that hydrogen ions were leached from the scaffold or 
the buffer reacted with the scaffold to produce acid. A possible reason for the drop in 
pH was residual acetic acid that was not washed away with the ethanol series. A 
similar observation was found by She, Zhang, Jin, Feng, & Xu,,pH dropped from 7.4 
to 6.92 in 1 hour, and then to 6.53 in 24 hours. Differences in the experiment involve 
silk fibroin instead of HA, and a longer degradation time (8 weeks). Silk fibroin is a 
widely used fibrous protein in biomedical applications due to its biocompatibility and 
mechanical properties and is similar to CS hydrophilicity and therefore degradation. 
Hence it is thought not to be the cause of the pH drop, but the AA (83).  
 
Limitations of this experiment included the use of static culture for scaffolds and 
small volumes of PBS. In a physiological system, this local acidity would be 
transported away from the site of production and have minimal effect of the local 
environment. To mimic this, PBS should be replaced frequently. The small volume of 
PBS used may have exaggerated the drop in pH as hydronium ions could exhaust the 
buffer. Larger volumes of PBS may be able to discriminate how likely the acidity is. 
Acidity must be controlled, a study by Han et al. suggested that acidic environments 
inhibit osteoblasts and stimulate osteoclasts leading to an osteoporotic environment 
(84).  However, osteoclast function may improve graft incorporation by tunneling into 
the scaffold and promote neovascularization (9).  
 
Additional study of degradation and pH needs to look into introducing shear stress 
and media similar to blood to determine if the scaffold can withstand mechanical 
forces, and whether blood components negatively impair integrity. The use of a 
bioreactor would provide shear stress however; this was not possible as there were 




5.1.6.4 Swelling Studies 
There was a significant difference (Table 4.4) found in weight between 0 and 168 
hours in all samples and indicates that scaffolds are swelling and retaining fluid with 
time (described graphically by Figure 4.21). Swelling behaviour refers to water 
entering the material, combining with the hydrophilic groups and therefore, is 
influenced by amount of hydrophilic groups and intermolecular forces (56).  
 
According to Zo et al., swelling kinetics was an appropriate indicator of large pores 
that are interconnected, representing good nutrient transport. Their results 
demonstrated a swelling of 94% of its original weight in 120 seconds (85). Jana et al 
described a scaffold that had a swelling ratio of approximately 30% in 2 weeks. In 
contrast, the author’s experiment resulted in a mean swelling of 10% over 7 days. 
This vast difference may be accounted for by the method of scaffold manufacture.  
The scaffolds manufactured by Zo et al. were 1% (w/v) CS with 1% (w/v) HA, Jana 
et al. used an 8% (w/v) CS scaffold, whereas the author used 8% (w/v) CS with 5% 
(w/v) HA. A more concentrated solute should have attracted more water, but less CS 
may have resulted in thinner pore walls, that can distend and retain more water. 
Alternatively, the author’s scaffold could have had small pores that were not 
interconnected. But this was not the case; as SEM and µCT imaging have shown 
appropriate pore sizes and adequate porosity similar to trabecular bone. It is 
hypothesized that the mechanical integrity of the author’s CS/nHA scaffold was 
superior leading to less swelling and deformation. 
 
Additional studies need to look further into the effects of swelling of a scaffold once 
implanted. This may be beneficial as this ensures surface area is in contact between 
the scaffold and the implantation site, or harmful if the swollen scaffold increases the 
local pressure and inhibiting blood flow. It may be necessary to keep the scaffold in 
fluid prior to seeding with cells to make sure it reaches its maximum swelling. A 
longer time period for static culture may be required to see if the scaffolds swell 
further in 1 week. 
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5.1.6.5 Fourier Transform Infrared Spectroscopy 
The Fourier transform infrared (FTIR) spectra of an 8% (w/v) CS and 5% (w/v) nHA 




 absorption band, which infers carbonated HA (37,59). A summary of 
FTIR peaks and bands can be found below in Table 5.1. 
 
Table 5.1: Summary of Fourier Transform Infrared Spectroscopy Peaks and Bands with 
Associated Characteristics. Contains typical peaks and bands for chitosan and hydroxyapatite 
spectroscopy. 
Sample Peak/Band (cm-1) Description 
Chitosan 1252 




NH2 of glucosamine 

























As depicted by FTIR spectra results (Figure 4.22), absorption bands of chitosan 
peaked around 3430 cm-1- due to the stretching vibration of OH and N-H groups (86). 
The presence of amide I and II peaks (1650, and 1606 cm-1 respectively) indicated 
that the CS used is not fully deacylated (87). 
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The spectra of nHA showed characteristic peaks v3 (PO4
3-) at 1050-1089 cm-1, v1 
(PO4
3-) at 962 cm-1, v(CO3
2-) at 1459 cm-1. A small band was observed at 3571 cm-1 
that corresponded to v(OH) (86) The band at 1461 cm-1 corresponded to CO3
2- and 





Additional study should repeat FTIR with a CS only scaffold and a nHA only 
scaffold. This will allow us to compare the composite scaffold with these and allow us 
to determine if there is a shift in the peaks, and whether these peaks were a result of 
formed chemical bond between CS and nHA, or if there is no shift, then the 
composite is only a mixture. Using FTIR on scaffolds with lower and higher amounts 
of CS and nHA compared to the composite can determine if some of the CS or nHA 
peaks are small or absent. 
 
5.1.6.6 Energy Dispersive X-Ray Spectroscopy 
As shown in Figure 4.23, the elemental composition of the scaffolds determined by 
energy dispersive X-ray spectroscopy (EDS) indicated large peaks of sodium and 
chloride, carbon and oxygen, with smaller peaks for phosphorus, potassium, and 
calcium. There was the absence of a nitrogen peak.  
 
The anomaly for large sodium and chloride could be explained as the scaffolds were 
kept in storage using saline buffer that contains physiological quantities of these ions, 
therefore once dehydrated prior to analysis these ions were left in the structure and 
analyzed with EDS. The presence of various ions may be beneficial for bone tissue 
engineering. Doreya, Amany, & Sara stated that substitution of silicon and additional 
carbonate in place of phosphorous improves solubility, and bioactivity can be 
increased as shown by in vitro and in vivo studies (89). Sang et al. demonstrates that 
sodium substitution into HA resulted in enhanced osteoconduction (90). Cho, Yoo, 




Additional studies involving ion substitution may be beneficial for these scaffolds, 
especially determining a way to dissolve more HA into solution. It must be looked 
into if the residual ions from the buffer can be washed away with fluid or if it indeed 
has been permanently incorporated into the structure. If ions are washed away, static 
cell culture on scaffolds that have these additional ions may improve bioactivity until 
placed in the bioreactor, until perfusion washes the ions away. 
 
It was found that the mole ratio of calcium to phosphorus was 1.92, 1.43 and 1.045 in 
3 random regions of the scaffold, suggesting different phases of precipitated calcium 
phosphate throughout the scaffold. For calcium hydroxyapatite, this ratio is 1.67. 
These ratios determined what type of calcium phosphate is analyzed (at a specific 
location by EDS) when combined with molecular formulae.  For example, tricalcium 
phosphate was 1.5, tetracalcium phosphate was 2.0, and octacalcium phosphate was 
1.33 (92). This ratio could indicate inferior mechanical properties and other calcium 
phosphate phases if the ratio was not 1.67 (93). The author’s results suggested that 
there was variation in calcium phosphate throughout the scaffold, however this was 
similar to ratios found in bone that range between 1.37 – 1.87 (94) and may be due to 
the variation of minerals. This variation may be due to heterogenous conditions 
through the scaffold (concentration, temperature, pH). The presence of trace elements, 
sodium and chloride may be the variation that caused the differences in calcium 
phosphate ratios. Nitrogen should have been present as CS was a polysaccharide with 
an amine group on each monosaccharide unit. The absence of a nitrogen peak may be 
explained due to low concentrations of CS used or the approach of how EDS was 
used. It is suggested to trial X-ray diffraction to determine the solid phases within the 
CS scaffold. 
 
5.2 Cell Culture Experiments 
5.2.1 Cell Viability LIVE/DEAD® Assay 
As CS was a biocompatible polymer that has increased bioactivity and 
osteoconduction from nHA, it was expected that the cell line would exhibit excellent 
viability (89). However, data shown in Figure 4.24 (A) indicated non-optimal 
viability at 24 and 48 hours (73%) with good viability (87%) at 96 hours. In 
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comparison to the viability on coverslips, there was no statistically significant 
difference between them.  
 
As shown in Table 4.5 (blue color), there was a significant difference of viability 
between 96 hours and both 24 and 48 hours of culture. This indicated that cells were 
increasing in viability over the course of cell culture. A study by Zo et al 
demonstrated that a CS and nHA composite scaffold showed excellent viability, with 
statistically significant differences between scaffold and static culture (85). Another 
study demonstrated viability of 95% using a 2% (w/v) CS scaffold (95). Reasoning 
behind the low viability at 24 and 48 hours may be due to poor cell culture techniques 
prior to seeding, and therefore resulting in higher amounts of dead cells. The increase 
in viability at 96 hours was likely due to cell proliferation of healthy cells in higher 
quality conditions and removal of dead cells with media replacement. 
 
As shown by Figure 4.24 (B), total cell number increased with time however this was 
not statistically significant (Table 4.5, red color) and may be due to low sample sizes 
(n = 3). Viability and total cell number combined gives a complete view of the 
cellular response to the scaffold. If for example, viability were 90% this would 
demonstrate excellent viability. However, if combined with a total cell number of 10 
this shows there were very few cells present and represents cytotoxicity (96). 
Therefore with high viability and total cell number this indicated the scaffold was 
biocompatible. 
 
The scaffold and coverslip experiments (Figure 4.27) demonstrated no significant 
differences between viability and total cell number. The coverslip acted as the control 
and should have demonstrated high viability of cells. This indicated that there was a 
flaw in cell culture techniques as it was the same in both experimental and control 
groups. Future work to improve cell viability should look into frequent media 
changing to remove debris that could be detected as dead by the assay. Cells must 
also be passaged at 70-80% confluence to ensure fast growth of cells and hence high 
viability. Additionally, as there was no statistically significant difference in viability 
between scaffolds and coverslips, this indicates two things. Firstly, the scaffold was 
non-toxic as it is similar to the glass coverslip and secondly, there was no additional 
benefit from growing cells on scaffolds.  
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5.2.2 CellTiter 96® AQueous One Solution Cell Proliferation Assay  
Figure 4.28 demonstrated similar absorbances of CS/nHA and collagen, with both 
increasing with culture time. Triton-X absorbance was very close to zero at all time 
points. This demonstrated that cells were proliferating in both CS and collagen 
vehicles and that no proliferation was occurring in Triton-X vehicles. 
 
Collagen is a widely used biomaterial with biocompatibility properties and is suitable 
for a cell proliferation assay negative control (97), as it will not cause a cytotoxic 
response. Therefore, as CS and collagen’s absorbances were very similar throughout 
the culture period (with no statistically significant differences) it is suggested that the 
scaffold was biocompatible and non-cytotoxic. Triton-X is a detergent and disrupts 
any membranous structure, preventing proliferation. Hence it was appropriate as a 
positive control as it will cause a cytotoxic response. The statistically significant 
differences in absorbance found between CS and collagen, and Triton-X supported 
that CS and collagen are non-cytotoxic. A statistically significant difference was 
found between CS and Triton-X absorbance at 0 hours. This may be due to the 
leeching of CS or nHA into solution, or the slight metabolizing of MTT and therefore 
altered absorbance values.  
 
The author’s experiment followed a study by Stace and showed very similar results, 
where CS and collagen showed no toxicity and Triton-X was toxic (39). This further 
supported that the CS/nHA scaffold was non-toxic and is appropriate for cell culture. 
Additionally, the data indicated that any steps in the production of the scaffold to post 
sterilizing supported the suitability for cell culture as no known toxic factors have 
been introduced, or have been removed during scaffold preparation. 
 
5.2.3 Perfusion Circuit Three-Dimensional Cell Culture of SAOS-2 
A limitation of this study was the availability of only one bioreactor. This combined 
with time constraints limits multiple uses and the inability for statistical analyses. 
Because of this, 3D culture is compared to 2D static culture on coverslips. Future 
research should involve the production of several bioreactors. This will allow various 
factors to be manipulated such as shear stress, seeding density and growth mediums.  
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5.2.3.1 Histology Protocol 
Our work indicated that 3D cell culture of SAOS-2 cells seeded onto a scaffold for 14 
days in a bioreactor resulted in the detection of clusters of cells that have proliferated 
from the surface of seeding to slightly deeper into the scaffold. There were some cells 
present throughout the scaffold and existed as singular entities. The cells were 
prominently detected by H&E staining and less by other stains. 
 
As shown by Figure 4.29, the H&E stained individual structures purple throughout 
the pink CS matrix. As haematoxylin stains acidic structures purple it indicated that 
nuclei, ribosomes and/or rough endoplasmic reticulum have been stained. This 
indicated that cells were living prior to fixation as degradation of DNA and nuclei 
occurred prior to cell death (98). Alternatively, the cytoplasm may not be easily seen 
due to the nature of sectioning, or the nucleus:cytoplasm ratio may be large just as 
seen in lymphocytes. Future study should use a portion of the scaffold immediately 
after bioreactor cell culture for LIVE/DEAD® viability assay to determine if cells are 
indeed living or dead and will provide insight into how far cells have penetrated the 
scaffold.  
 
Fluorescent microscopy (Figure 4.30) revealed the yellow auto-fluorescence of eosin 
stained matrix and green structures that looked like cells (525 nm excitation and 545 
nm emission). This indicated that the matrix (which consists of CS and nHA) readily 
took up eosin as a stain. Similarly to Baker et al, the cationic chitosan took up anionic 
eosin well due to opposite charges, and auto-fluoresced (99). The green structure did 
not auto-fluoresce like CS, thus it did not take up eosin. This further supported that 
the green structures were synonymous with the haematoxylin stained purple structures 
in H&E staining. As eosin has stained the CS and nHA matrix pink (as shown by 
Figure 4.29 H&E staining) these were the only structures that auto-fluoresce with 
light microscopy. Additionally, these green structures were not confined to the matrix 
whereas CS/nHA are. To additionally confirm cells were viable, the scaffold must be 




A study by Wang et al demonstrated the biocompatibility of 2 x 106 MSCs seeded 
onto a polyamide/nHA scaffold using phase-contrast microscopy. This in vitro study 
observed at 3 days that large amounts of cells migrated and proliferated into the pores 
with no sign of toxicity. Compared to the author’s study, which seeded cells for 24 
hours before placement into a bioreactor, this was static culture in a well plate for up 
to 7 days (100). It may be beneficial for future studies to employ static culture on a 
scaffold for a longer duration prior to bioreactor usage, to allow cell attachment and 
proliferation throughout the scaffold before exposure to shear stress, which may have 
negatively affected proliferation and ECM production in the author’s work. Work by 
Seol et al. showed that seeding 1 x 107 MSC cells/g of CS scaffold (3% (w/v) CS, 
with similar pore diameters to the author) resulted in attachment, and rapid 
proliferation of cells in 28 days of static culture (101). This further supported the use 
of static culture of scaffolds prior to bioreactor implementation.  Both Wang and Seol 
seeded MSC cells at a high density compared to the author, 1000-10,000 times larger 
in comparison to the author’s 6000 seeded cells per scaffold. Work by Holy, Shoichet 
and Davies suggested that the initial seeding density (ranging from 0.5 – 10 x 106 
cells/cm3) did not significantly affect the formation of tissue, but lower densities 
delayed the production of mineralization (102). The very low magnitude of seeding 
by the author may have negatively impaired cell penetration and proliferation, or 14 
days culture simply was not enough time for cells to organize and form tissue. It is 
recommended to seed cells at a 106 or similar magnitude. Future study should 
investigate the optimal seeding density onto CS/nHA scaffolds for the generation of 
osteoid tissue, using a cell proliferation assay and histology for analysis.  
 
Another factor involved in cell proliferation in 3D culture is shear stress. Shear stress 
was introduced as 1 mL/min perfusion through the system. This showed that this rate 
resulted in viable cells. Studies showed that a 1 mL/min, continuous flow (non-
pulsatile) enhanced proliferation, calcium deposition and expression of bone marker 
proteins (67). Similarly, another study reported that flow rates of 0.3, 1 and 3 mL/min 
resulted in increased proliferation, alkaline phosphatase and bone marker expression, 
and mineralization (68). In light of these studies, where this increased proliferation 
was not observed and indicated that the author’s fluid flow may need to be altered as 
the bioreactor used was the first of its kind. In contrast, another study showed that 1 
mL/min resulted in cell death and low viability and recommended lower flows of 
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0.01, 0.1 and 0.2 mL/min as they resulted in higher viability, proliferation and 
expression of DNA and RNA (69). Although 1 mL/min was manually measured this 
may be completely different to the forces that the cells are exposed to, as there are 
cross sectional areas that differ in size throughout the circuit. Future study should start 
at very low fluid flows until tissue has been generated. Shear stress can then be 
investigated at varying rates to determine the optimal flow that enhances cell 
proliferation. 
 
Sectioning of the scaffold additionally revealed the porous architecture with a 
heterogeneous matrix due to fabrication of scaffold by both CS and nHA. Various 
lightly stained portions within the CS matrix were found in H&E, Masson’s 
Trichrome (Figure 4.31), Alizarin Red (Figure 4.32), Von Kossa (Figure 4.33) and 
Van Gieson (Figure 4.34) stained scaffolds. These light areas are indicative of nHA 
clumps that have dispersed throughout. Although none of these stained specifically 
for nHA (except for alizarin red), we can speculate this is the case, as there was no 
light stained areas found in the control scaffold. Alizarin red intensely stained a 
coverslip of SAOS-2 cells, whereas the staining was not as intense in the CS/nHA 
scaffold. A possible reason for this reduction in staining intensity of mineralization on 
a scaffold section was likely to be the decalcification step during microtome 
sectioning, which was required due to destruction of the sections by the microtome. 
 
The porous architecture of the scaffold was evident by histological staining and 
microtome sectioning. This further supports SEM and µCT analysis that have 
determined this also. In all histological images of the scaffold, there were noticeable 
thick and thin walls in the CS matrix with no noticeable pattern. This means that the 
process of scaffold generation produced irregular walls. Compared to a scaffold by 
Stace, who used 1% (w/v) CS and 0.25% (w/v) nHA to prepare the composite, there 
were only thin walls with no clumping (39). This suggested that the nature of these 
clumps was due to high concentrations of CS/nHA that may not have been mixed 
sufficiently with AA. Additional study needs to look into a way for the homogenous 
distribution of CS and nHA. This may involve looking into the mixing of solutes and 
freezing conditions as mentioned above in 5.2.1. 
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An unexpected finding occurred during 3D culture. At 7 and 14 days of culture, pH 
was measured after replacing the media. The media increased from 7.4 to 7.62 on 
both occasions. This indicated that acidity was lost or alkalinity was added to the 
media during cell culture. A study demonstrated that DNA and collagen synthesis 
increase, but a reduction in ALP expression at a slightly alkaline pH (103,104). This 
may negatively impair the mineralization of the osteoid tissue. Kaysinger 
demonstrated that a pH of 7.0 – 7.6 was a suitable range for osteoblast support (104). 
As the pH is just above this range there should be no significant effect on cells.  The 
cause of this pH change could be reduced cellular metabolism or diffusion of gases 
through the tubing. As cells were present, this eliminated metabolism as a factor, 
although they may have lowered metabolism, as they were not proliferating. The 
tubing, which passed out of the incubator to the peristaltic pump, was in contact with 
a very low atmospheric CO2. As this tubing allowed gas exchange CO2 will be lost 
and therefore a loss of acidity. Future use of the bioreactor should limit the length of 
tubing outside of the incubator, a change of non-permeable tubing for outside the 
incubator and increasing the length of tubing inside the incubator for CO2 
equilibration.  
 
5.2.4 Bone Marrow Culture 
The results of bone marrow culture showed a heterogenous cells population of spindle 
and flat cells (Figure 4.35). It appeared that passaging cells reduced their ability to 
proliferate and/or become senescent with an increase in the ratio of flat:spindle cells. 
Further investigation of these cells for differentiation down the osteoblastic lineage 
and subsequent 3D culture was unable to be attemped due to insufficient cells. 
 
The cell culture of bone marrow resulted in a heterogeneous cell population that was 
evident prior to the first passage. This indicated that bone marrow contained several 
phenotypes or morphologies of cells. A study by Neuhuber et al. demonstrated 6 
morphologically distinct cell sub-populations after the culture of Fischer rat marrow. 
3 subpopulations showed elongated, ‘spindle’ shapes while the other 3 had ‘flat’, 
polygonal morphologies with little or no processes. The author’s study showed both 
these populations in vitro. Alternatively, the culture could be contaminated with non-
stem cell populations from marrow. However, mesenchymal stem cells (MSCs) are 
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differentiated by other cells by their ability to adhere to tissue culture plastic, and 
therefore non-MSCs should be removed by media replacement (42). Implications of 
this heterogeneity are the ability of these cells to proliferate and differentiate. Spindle 
cells had faster population doublings compared to the flat cells, and flat cells had a 
reduced ability to differentiate down the chondrogenic and adipogenic lineages (105).  
During cell expansion, it appeared that passaging prior to 70-80% confluence reduced 
the ability for cell proliferation and caused a relative decrease of spindle cells or 
increase in flat cells. This showed two things; firstly, detachment by trypsin may have 
negatively influenced cell division if done prior to, or during, early log phase. And 
secondly, spindle cells are lost, transformed to flat cells, or the flat cells are 
preferentially grown during a passage. A study by Bonab et al. showed that cells 
begin senescence and lose stem cell characteristics the moment in vitro culture began 
(106). As a result, cells must be used as soon as possible for experiments and 
expanded as little as possible. As an adult Wistar rat was used for its bone marrow it 
may have adverse of stem cell culture as mentioned above. A clinical consequence 
may be the use of elderly mesenchymal stem cells that have reduced proliferation and 
therefore a higher chance of cell culture failure. Therefore, implementing these stem 
cell technologies may require the harvesting of cells at a young age that are 
cryopreserved for later use in life. 
 
Also shown by Neuhuber, it was found that the ratio of spindle to flat cells decreased 
over time and suggested that spindle cells are ‘immature’ and flat cells are ‘mature’ 
stem cells (105). This supports the author’s study, as spindle cells decreased with 
passaging, or time in general. It is possible that the spindle cells ‘differentiate’ into 
flat cells with time when stimulated by in vitro experimentation. Both spindle and flat 
cells could be seen individually or in clusters and showed that their proliferative 
potential still exists. A consequence of more flat cells was the reduced ability to 
differentiate down adipogenic and chondrogenic lineages. However, this did not apply 
to the field of bone engineering. Therefore bone marrow cells require less stringent 
protocols for cell culture. 
 
Future studies should look into the optimization of stem cell proliferation. A 
modification to the protocol by Stace will be to not passage cells after 3 days of 
marrow isolation and instead should let cells become confluent to 70-80% and then 
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passaged 3 additional times. Additionally, following a protocol established in the Dias 
Lab, cells can be grown in plastic dishes after isolation, this will allow easy access for 
a cloning cylinder that will be placed on top of a proliferating spindle shaped colony, 
which can undergo subsequent detachment with trypsin. The cells can then be 
aspirated and resuspended to grow pure spindle-shaped cells. Confirmation of stem 





















6 Conclusions and Future Directions 
 
6.1 Scaffold Production 
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It was found that the development of pores was temperature dependent, -80 °C will 
not result in a porous structure, but form layers. 22 °C was found to be appropriate for 
pore development. Additionally, freezing conditions such as duration can influence 
the porous geometry. The use of hydroxyapatite to form a composite scaffold with 
chitosan exhibited favor to that of the nano scale, as a larger amount could be used 
without causing the scaffold to become friable or form layers. In contrast to the 
majority of literature, 8% (w/v) chitosan was used to produce a scaffold with adequate 
pore diameters, porosity and structural integrity. The structural parameters were 
maintained with the addition of 5% (w/v) nano-hydroxyapatite with average pore 
sizes above 100 µm and a porosity of 79%. 
 
6.2 Scaffold Characterization 
 
Scaffolds that were rehydrated by ethanol series did not show any significant 
structural changes and could be immersed in aqueous media without dissolving. 
Autoclaving demonstrated an effective way of sterilization with no change in the 
porous architecture other than a physical change in color. Scaffolds did not degrade 
significantly in vitro but the local pH surrounding scaffolds reduced from 7.4 to 6.98. 
It was shown that scaffolds swelled approximately 10% after immersion in aqueous 
solution. Fourier transform infrared spectroscopy showed that hydroxyapatite was 
incorporated into the chitosan scaffold. Energy Dispersive Spectroscopy demonstrated 
the presence of chitosan and hydroxyapatite, with the presence of high chloride and 
sodium peaks due to storage of scaffolds in saline.  
6.3 Cell Culture Experiments 
 
The LIVE/DEAD® assay showed that Osteogenic Sarcoma cells (SAOS-2) were 
viable with no significant difference compared to 2D culture on glass coverslips. A 
CellTiter 96® MTS proliferation demonstrated that cells proliferated when exposed to 
scaffold vehicles. Both assays demonstrated that the scaffold was biocompatible and 
did not contain any cytotoxins. 3D culture of SAOS-2 cells on a scaffold for 14 days 
at a flow rate of 1 mL/min resulted in the appearance of cells within the scaffold. 
These cells were concentrated at the cell seeded end with few dispersed deeper 
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through the scaffold. Histology showed the presence of cells and additionally 
demonstrated the porous nature and the incorporation of hydroxyapatite in the 
scaffold. Isolation of mesenchymal stem cells proved initially successful with the 
presence of a heterogenous cell population of spindle and flat cells. The proliferative 
capacity of these cells reduced with passaging and resulted in senescence.  
 
6.4 Future Directions 
 
There are several areas highlighted by this research for which further investigation 
should be sought after. Firstly, cells were found on the scaffold after 3D culture, once 
mesenchymal stem cell proliferation, differentiation, seeding and extracellular matrix 
production have been optimized the study should proceed into animal trials. Using 
Lewis rats, we can isolate stem cells and generate a cell-scaffold construct that has 
been grown in the bioreactor. As Lewis rats are genetically identical, the scaffold can 
be implanted into 8 mm critical sized calvaria defects without rejection. Here we can 
compare the scaffold against rats that have calvaria autografts to determine efficacy of 
bone healing by these synthetic grafts and whether this has been stimulated in critical 
defects. 
 
Secondly, the use of high concentrations of chitosan to produce a scaffold 
demonstrates higher structural integrity. The scaffolds should be mechanically tested 
to measure tensile and compressive strength and/or a nano-indenter to test hardness. 
Therefore, we can compare and contrast between current bone graft substitutes. As 
chitosan can be molded into various shapes, this may lead onto the future use of 
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Appendix A – Pore Measurement Supplementary Data 
Table A1: Mean pore diameter of 3 SEM images of a 8%CS/5%nHA (w/v) 
scaffold. 
 
Pore Number Scaffold 1 Scaffold 2 Scaffold 3 
1 87.49 174.62 139.57 
2 60.96 137.82 118.01 
3 85.12 128.75 78.06 
4 87.51 107 115.78 
5 101.98 95.76 142.65 
6 121.87 99.76 90.62 
7 116.64 61.36 130.99 
8 98.64 92.56 77.51 
9 107.89 81.48 100.97 
10 105.57 99.31 88.19 
11 74.54 126.15 129.67 
12 115.7 114.76 73.69 
13 114.44 64.38 95.05 
14 114.43 112.02 104.39 
15 138.59 109.24 94.46 
16 123.67 115.31 102.37 
17 103.18 102.18 100.93 
18 61.38 134.47 96.2 
19 109.47 128.93 103.55 
20 100.32 97.43 102.25 
 140 
21 122.45 96.97 77.51 
22 127.28 132.75 101.91 
23 108.21 146.68 113.15 
24 124.37 140.83 85.83 
25 140.65 78.47 128.79 
26 118.25 89.94 103.4 
27 103.46 103.61 115.4 
28 128.66 83.72 116.7 
29 55.35 99.7 92.15 
30 99.85 101.82 103.7 
Mean (µm) 105.26 106.59 104.12 
Minimum 55.35 61.36 73.69 
25% Percentile 95.86 94.96 93.50 
Median 108.1 102.9 102.1 
75% Percentile 122.0 128.8 116.0 
Maximum 140.7 174.6 142.7 
Lower 95% CI of mean 97.13 99.29 97.33 
Upper 95% CI of mean 113.4 117.9 110.9 
n 30 30 30 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
